<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for palliative symptom control in COVID‐19 patients - Andreas, M - 2021 | Cochrane Library</title> <meta content="Interventions for palliative symptom control in COVID‐19 patients - Andreas, M - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015061/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for palliative symptom control in COVID‐19 patients - Andreas, M - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015061/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD015061" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for palliative symptom control in COVID‐19 patients" name="citation_title"/> <meta content="Marike Andreas" name="citation_author"/> <meta content="Faculty of Medicine and University Hospital Cologne, University of Cologne" name="citation_author_institution"/> <meta content="Vanessa Piechotta" name="citation_author"/> <meta content="Faculty of Medicine and University Hospital Cologne, University of Cologne" name="citation_author_institution"/> <meta content="vanessa.piechotta@uk-koeln.de" name="citation_author_email"/> <meta content="Nicole Skoetz" name="citation_author"/> <meta content="Faculty of Medicine and University Hospital Cologne, University of Cologne" name="citation_author_institution"/> <meta content="Kathrin Grummich" name="citation_author"/> <meta content="Cochrane Germany Foundation" name="citation_author_institution"/> <meta content="Marie Becker" name="citation_author"/> <meta content="University of Cologne" name="citation_author_institution"/> <meta content="Lisa Joos" name="citation_author"/> <meta content="Faculty of Medicine, University of Freiburg" name="citation_author_institution"/> <meta content="Gerhild Becker" name="citation_author"/> <meta content="Faculty of Medicine, University of Freiburg" name="citation_author_institution"/> <meta content="Winfried Meissner" name="citation_author"/> <meta content="University Hospital of Jena" name="citation_author_institution"/> <meta content="Christopher Boehlke" name="citation_author"/> <meta content="Faculty of Medicine, University of Freiburg" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD015061" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/08/23" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015061/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015061/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015061/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Bias; COVID-19 [diagnosis, *therapy]; *Palliative Care; SARS-CoV-2; Systematic Reviews as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015061&amp;doi=10.1002/14651858.CD015061&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="wbKFI7vu";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD015061\x26doi\x3d10\x2e1002\x2f14651858\x2eCD015061\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015061\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015061\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ko","ms","hr","fr","zh_HANS","zh_HANT","th","ja","fa","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD015061",title:"Interventions for palliative symptom control in COVID\\u201019 patients",firstPublishedDate:"Aug 23, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pain, Palliative and Supportive Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=wbKFI7vu&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD015061&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD015061';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD015061/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD015061/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD015061%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD015061/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD015061/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD015061/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD015061/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD015061" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD015061/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD015061" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD015061/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD015061/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>11089 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD015061" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015061/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015061/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-sec-0091"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-sec-0048"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-sec-0077"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD015061/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015061/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015061/appendices#CD015061-sec-0095"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015061/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015061/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015061/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015061/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD015061/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD015061/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD015061/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD015061/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for palliative symptom control in COVID‐19 patients</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015061/information#CD015061-cr-0004">Marike Andreas</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015061/information#CD015061-cr-0005"><i class="icon corresponding-author fa fa-envelope"></i>Vanessa Piechotta</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015061/information#CD015061-cr-0006">Nicole Skoetz</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015061/information#CD015061-cr-0007">Kathrin Grummich</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015061/information#CD015061-cr-0008">Marie Becker</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015061/information#CD015061-cr-0009">Lisa Joos</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015061/information#CD015061-cr-0010">Gerhild Becker</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015061/information#CD015061-cr-0011">Winfried Meissner</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015061/information#CD015061-cr-0012">Christopher Boehlke</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD015061/information/en#CD015061-sec-0121">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 23 August 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD015061/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD015061">https://doi.org/10.1002/14651858.CD015061</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD015061-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD015061-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD015061-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD015061-abs-0019">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD015061-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD015061-abs-0005">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD015061-abs-0016">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD015061-abs-0013">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD015061-abs-0001" lang="en"> <section id="CD015061-sec-0001"> <h3 class="title" id="CD015061-sec-0001">Background</h3> <p>Individuals dying of coronavirus disease 2019 (COVID‐19) may experience distressing symptoms such as breathlessness or delirium. Palliative symptom management can alleviate symptoms and improve the quality of life of patients. Various treatment options such as opioids or breathing techniques have been discussed for use in COVID‐19 patients. However, guidance on symptom management of COVID‐19 patients in palliative care has often been derived from clinical experiences and guidelines for the treatment of patients with other illnesses. An understanding of the effectiveness of pharmacological and non‐pharmacological palliative interventions to manage specific symptoms of COVID‐19 patients is required. </p> </section> <section id="CD015061-sec-0002"> <h3 class="title" id="CD015061-sec-0002">Objectives</h3> <p>To assess the efficacy and safety of pharmacological and non‐pharmacological interventions for palliative symptom control in individuals with COVID‐19. </p> </section> <section id="CD015061-sec-0003"> <h3 class="title" id="CD015061-sec-0003">Search methods</h3> <p>We searched the Cochrane COVID‐19 Study Register (including Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (PubMed), Embase, ClinicalTrials.gov, World Health Organization International Clinical Trials Registry Platform (WHO ICTRP), medRxiv); Web of Science Core Collection (Science Citation Index Expanded, Emerging Sources); CINAHL; WHO COVID‐19 Global literature on coronavirus disease; and COAP Living Evidence on COVID‐19 to identify completed and ongoing studies without language restrictions until 23 March 2021. </p> <p>We screened the reference lists of relevant review articles and current treatment guidelines for further literature. </p> </section> <section id="CD015061-sec-0004"> <h3 class="title" id="CD015061-sec-0004">Selection criteria</h3> <p>We followed standard Cochrane methodology as outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>. </p> <p>We included studies evaluating palliative symptom management for individuals with a confirmed diagnosis of COVID‐19 receiving interventions for palliative symptom control, with no restrictions regarding comorbidities, age, gender, or ethnicity. Interventions comprised pharmacological as well as non‐pharmacological treatment (e.g. acupressure, physical therapy, relaxation, or breathing techniques). We searched for the following types of studies: randomized controlled trials (RCT), quasi‐RCTs, controlled clinical trials, controlled before‐after studies, interrupted time series (with comparison group), prospective cohort studies, retrospective cohort studies, (nested) case‐control studies, and cross‐sectional studies. </p> <p>We searched for studies comparing pharmacological and non‐pharmacological interventions for palliative symptom control with standard care. </p> <p>We excluded studies evaluating palliative interventions for symptoms caused by other terminal illnesses. If studies enrolled populations with or exposed to multiple diseases, we would only include these if the authors provided subgroup data for individuals with COVID‐19. We excluded studies investigating interventions for symptom control in a curative setting, for example patients receiving life‐prolonging therapies such as invasive ventilation.  </p> </section> <section id="CD015061-sec-0005"> <h3 class="title" id="CD015061-sec-0005">Data collection and analysis</h3> <p>We used a modified version of the Newcastle Ottawa Scale for non‐randomized studies of interventions (NRSIs) to assess bias in the included studies. We included the following outcomes: symptom relief (primary outcome); quality of life; symptom burden; satisfaction of patients, caregivers, and relatives; serious adverse events; and grade 3 to 4 adverse events. </p> <p>We rated the certainty of evidence using the GRADE approach. </p> <p>As meta‐analysis was not possible, we used tabulation to synthesize the studies and histograms to display the outcomes.  </p> </section> <section id="CD015061-sec-0006"> <h3 class="title" id="CD015061-sec-0006">Main results</h3> <p>Overall, we identified four uncontrolled retrospective cohort studies investigating pharmacological interventions for palliative symptom control in hospitalized patients and patients in nursing homes. None of the studies included a comparator. We rated the risk of bias high across all studies. We rated the certainty of the evidence as very low for the primary outcome symptom relief, downgrading mainly for high risk of bias due to confounding and unblinded outcome assessors. </p> <p><b>Pharmacological interventions for palliative symptom control</b> </p> <p>We identified four uncontrolled retrospective cohort studies (five references) investigating pharmacological interventions for palliative symptom control. Two references used the same register to form their cohorts, and study investigators confirmed a partial overlap of participants. We therefore do not know the exact number of participants, but individual reports included 61 to 2105 participants. Participants received multimodal pharmacological interventions: opioids, neuroleptics, anticholinergics, and benzodiazepines for relieving dyspnea (breathlessness), delirium, anxiety, pain, audible upper airway secretions, respiratory secretions, nausea, cough, and unspecified symptoms.  </p> <p><i>Primary outcome: symptom relief</i> </p> <p>All identified studies reported this outcome. For all symptoms (dyspnea, delirium, anxiety, pain, audible upper airway secretions, respiratory secretions, nausea, cough, and unspecified symptoms), a majority of interventions were rated as completely or partially effective by outcome assessors (treating clinicians or nursing staff). Interventions used in the studies were opioids, neuroleptics, anticholinergics, and benzodiazepines.  </p> <p>We are very uncertain about the effect of pharmacological interventions on symptom relief (very low‐certainty evidence). The initial rating of the certainty of evidence was low since we only identified uncontrolled NRSIs. Our main reason for downgrading the certainty of evidence was high risk of bias due to confounding and unblinded outcome assessors. We therefore did not find evidence to confidently support or refute whether pharmacological interventions may be effective for palliative symptom relief in COVID‐19 patients. </p> <p><i>Secondary outcomes</i> </p> <p>We planned to include the following outcomes: quality of life; symptom burden; satisfaction of patients, caregivers, and relatives; serious adverse events; and grade 3 to 4 adverse events. </p> <p>We did not find any data for these outcomes, or any other information on the efficacy and safety of used interventions. </p> <p><b>Non‐pharmacological interventions for palliative symptom control</b> </p> <p>None of the identified studies used non‐pharmacological interventions for palliative symptom control. </p> </section> <section id="CD015061-sec-0007"> <h3 class="title" id="CD015061-sec-0007">Authors' conclusions</h3> <p>We found very low certainty evidence for the efficacy of pharmacological interventions for palliative symptom relief in COVID‐19 patients. We found no evidence on the safety of pharmacological interventions or efficacy and safety of non‐pharmacological interventions for palliative symptom control in COVID‐19 patients. The evidence presented here has no specific implications for palliative symptom control in COVID‐19 patients because we cannot draw any conclusions about the effectiveness or safety based on the identified evidence. More evidence is needed to guide clinicians, nursing staff, and caregivers when treating symptoms of COVID‐19 patients at the end of life. Specifically, future studies ought to investigate palliative symptom control in prospectively registered studies, using an active‐controlled setting, assess patient‐reported outcomes, and clearly define interventions. </p> <p>The publication of the results of ongoing studies will necessitate an update of this review. The conclusions of an updated review could differ from those of the present review and may allow for a better judgement regarding pharmacological and non‐pharmacological interventions for palliative symptom control in COVID‐19 patients.  </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD015061-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD015061-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD015061-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD015061-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD015061-abs-0020">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD015061-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD015061-abs-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD015061-abs-0018">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD015061-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD015061-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD015061-abs-0021">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD015061-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD015061-abs-0017">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD015061-abs-0014">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD015061-abs-0015">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD015061-abs-0002" lang="en"> <h3>Which treatments are best for symptoms in COVID‐19 patients at the end of life?</h3> <p><b>The burden of symptoms at the end of life of COVID‐19 patients and helpful treatments</b> </p> <p>COVID‐19 patients may show symptoms such as breathlessness or delirium at the end of life. The goal of palliative medicine is to relieve such symptoms with specific treatments. Treatments can be drugs, for example opioids, or non‐drugs, such as breathing techniques or relaxation.  </p> <p><b>What was the aim of our review?</b> </p> <p>To explore how well different interventions (drugs and non‐drugs) work for the treatment of palliative symptoms in COVID‐19 patients at the end of life. We included patients of all ages and with all comorbidities (additional medical conditions).  </p> <p><b>What type of studies did we search for?</b> </p> <p>We searched selected medical databases and trial registries until 23 March 2021. We included studies looking at how well different palliative treatments work to relieve COVID‐19‐associated symptoms at the end of life. We wanted to compare studies investigating different medicines or therapies, but we only found studies without a comparison group. Only one study reported the specific drugs used for individual symptoms. </p> <p><b>Key results</b> </p> <p>We found four studies that were published in five papers. Individual papers included between 61 and 2105 participants, and two papers partially reported on the same participants. All of the included studies investigated different drug treatments for palliative symptom management in people with COVID‐19. </p> <p><i>Drugs for symptom control at the end of life</i> </p> <p>All of the included studies reported on the effectiveness of palliative care for symptom relief. In all studies, clinicians or nursing staff rated symptom relief rather than the patients themselves. Since the quality of the evidence was very low, we do not know the true effect of drug treatments on symptom relief and have very low confidence in the results of the studies. We did not find any data on quality of life; symptom burden; satisfaction of patients, caregivers, and relatives; or safety of the drug treatments. </p> <p><i>Non‐drug therapies for symptom control at the end of life</i> </p> <p>We did not find any data on the benefits and harms of non‐drug therapies for symptom control of COVID‐19 patients at the end of life. </p> <p><b>Conclusions</b> </p> <p>Based on our findings, we could not draw any conclusions on palliative symptom control of people with COVID‐19. Future studies need to be designed better so that we can determine which treatments work for symptom control in people with COVID‐19.  </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD015061-sec-0091" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD015061-sec-0091"></div> <h3 class="title" id="CD015061-sec-0092">Implications for practice</h3> <section id="CD015061-sec-0092"> <p>We did not find evidence to confidently support or refute whether pharmacological interventions may be effective for palliative symptom relief in COVID‐19 patients, and no evidence on the safety of pharmacological interventions, or effectiveness and safety of non‐pharmacological interventions for palliative symptom control in COVID‐19 patients. The evidence presented here has no specific implications for palliative symptom control in COVID‐19 patients because we cannot draw any conclusions about the effectiveness or safety based on the identified evidence. More evidence is needed to guide clinicians, nursing staff, and caregivers when treating symptoms of COVID‐19 patients at the end of life. Specifically, future studies ought to investigate palliative symptom control in prospectively registered studies, using an active‐controlled setting, assess patient‐reported outcomes, and clearly define interventions. The identified evidence does not rule out current practice for palliative symptom control, for example for cancer.  </p> </section> <h3 class="title" id="CD015061-sec-0093">Implications for research</h3> <section id="CD015061-sec-0093"> <p>The results of our systematic review show that randomized controlled trials (RCTs) on the palliative symptom management of COVID‐19 patients are needed. However, as RCTs in the palliative setting are complex due to ethical and logistic constraints, well‐conducted prospectively registered observational studies would help to fill the current research gap. Specifically, future research ought to investigate treatments in prospectively registered studies, using a controlled setting, assess patient‐reported outcomes, and clearly define interventions.  </p> <p>We identified one RCT that may be already completed but for which results are not yet available, investigating the effects of acupressure therapy and Liu Zi Jue Qigong exercises on dyspnea and quality of life in individuals with COVID‐19. We further identified abstracts to three studies that might have relevant information on palliative symptom control once full texts are published. In addition, we found one ongoing study investigating morphine in COVID‐19 patients with dyspnea in a controlled setting.  </p> <p>The publication of the results of these studies will necessitate an update of this review. The conclusions of the updated review could differ from those of the present review and may allow for a better judgement regarding pharmacological and non‐pharmacological interventions for palliative symptom control in COVID‐19 patients.  </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD015061-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD015061-sec-0008"></div> <div class="table" id="CD015061-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Pharmacological interventions for palliative symptom control</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Pharmacological interventions for palliative symptom control for patients with COVID‐19</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients with COVID‐19 </p> <p><b>Intervention:</b> Pharmacological interventions </p> <p><b>Comparison:</b> None </p> <p><b>Outcome:</b> Palliative symptom control </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcome</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number of participants</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Certainty of the evidence</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Plain text summary</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptom relief</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 studies (5 references) with 61 to 2105 participants in individual studies<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>All studies rated a majority of interventions as effective in relieving symptoms of breathlessness, agitation, dyspnea, delirium, pain, and others. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Very low</b> </p> <p>Due to study design<sup>2</sup> and high risk of bias<sup>3</sup> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are very uncertain about the effect of palliative care interventions including opioids, neuroleptics, anticholinergics, and benzodiazepines on symptom relief. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Based on data from 0 participants in 0 studies</p> <p>Follow‐up: none</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported in any study.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptom burden</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Based on data from 0 participants in 0 studies</p> <p>Follow‐up: none</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported in any study.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction of patients</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Based on data from 0 participants in 0 studies</p> <p>Follow‐up: none</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported in any study.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction of caregivers </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Based on data from 0 participants in 0 studies</p> <p>Follow‐up: none</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported.<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported in any study.<br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction of relatives</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Based on data from 0 participants in 0 studies</p> <p>Follow‐up: none</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported in any study.<br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Based on data from 0 participants in 0 studies</p> <p>Follow‐up: none</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported.<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported in any study.<br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grade 3 to 4 adverse events<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Based on data from 0 participants in 0 studies</p> <p>Follow‐up: none</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported.<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported in any study.<br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>N/A: Not applicable </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>1</sup>Participants of the two cohorts reported on in <a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a> partially overlap, therefore we do not know the exact number of participants. </p> <p><sup>2</sup> Initial rating of certainty of the evidence: Rated low because all identified studies had a retrospective and uncontrolled design. <br/><sup>3</sup>Risk of bias: high. Lack of blinding of participants and personnel, resulting in the potential for detection bias in all studies. Lack of blinding of outcome assessors, resulting in the potential for detection bias in all studies. Selective outcome reporting, follow‐up not reported, missing intention‐to‐treat analysis, use of unvalidated outcome measures in <a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]">Alderman 2020</a>, <a href="./references#CD015061-bbs2-0003" title="LovellN , MaddocksM , EtkindSN , TaylorK , CareyI , VoraV , et al. Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care. Journal of Pain and Symptom Management2020;60(1):e77-81. [DOI: 10.1016/j.jpainsymman.2020.04.015]">Lovell 2020</a>, and <a href="./references#CD015061-bbs2-0002" title="HetheringtonL , JohnstonB , KotronoulasG , FinlayF , KeeleyP , McKeownA . COVID-19 and hospital palliative care—a service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist hospital palliative care. Palliative Medicine2020;34(9):1256-62. [DOI: 10.1177/0269216320949786]">Hetherington 2020</a>, and use of subjective outcome measures in all studies. Imprecision: none. Publication bias: none. Inconsistency: difficult to assess. Indirectness of evidence: difficult to assess.  </p> <p> </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD015061-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD015061-sec-0009"></div> <p>This work is part of a series of Cochrane Reviews investigating treatments and therapies for COVID‐19. Reviews of this series share information in the Background section and methodology based on the first published reviews about monoclonal antibodies, <a href="./references#CD015061-bbs2-0059" title="Kreuzberger N, HirschC , ChaiKL , PiechottaV , ValkSJ , EstcourtLJ , et al. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database of Systematic Reviews2021, Issue 1. Art. No: CD013825. [DOI: 10.1002/14651858.CD013825]">Kreuzberger 2020</a>, and convalescent plasma (<a href="./references#CD015061-bbs2-0092" title="Valk SJ, Piechotta V, Chai KL, Doree C, Monsef I, Wood EM, et al. Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review. Cochrane Database of Systematic Reviews2021, Issue 5. Art. No: CD013600. [DOI: 10.1002/14651858.CD013600.pub4]">Valk 2020a</a>).  </p> <section id="CD015061-sec-0010"> <h3 class="title" id="CD015061-sec-0010">Description of the condition</h3> <p>COVID‐19 is a highly infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2; <a href="./references#CD015061-bbs2-0097" title="World Health Organization (WHO). Report of the WHO‐China Joint Mission on coronavirus disease 2019 (COVID‐19). www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report (accessed prior to 9 August 2021).">WHO 2020a</a>). On 22 March 2020, the World Health Organization (WHO) declared the current COVID‐19 outbreak a pandemic. COVID‐19 is unprecedented in comparison to previous coronavirus outbreaks, such as severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), with 813 and 858 deaths, respectively (<a href="./references#CD015061-bbs2-0095" title="World Health Organization (WHO). Cumulative number of reported probable cases of SARS. www.who.int/csr/sars/country/2003_07_11/en/ (accessed 13 April 2020).">WHO 2007</a>; <a href="./references#CD015061-bbs2-0096" title="World Health Organization (WHO). Middle East respiratory syndrome coronavirus (MERS-CoV). www.who.int/emergencies/mers-cov/en/ (accessed 13 April 2020).">WHO 2019</a>). Despite intensive international efforts to contain its spread, it has resulted in more than 180 million confirmed cases and more than 4 million deaths worldwide until July 2021 (<a href="./references#CD015061-bbs2-0100" title="World Health Organization (WHO). WHO Coronavirus Disease (COVID-19) Dashboard. covid19.who.int (accessed 14 July 2021).">WHO 2021a</a>; <a href="./references#CD015061-bbs2-0101" title="World Health Organization (WHO). Weekly epidemiological update—13 July. www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---13-july-2021 (accessed 14 July 2021).">WHO 2021b</a>).  </p> <p>Several vaccines against COVID‐19 have been distributed across countries, and an additional hundred vaccine candidates are in development at the time of the writing of this review (<a href="./references#CD015061-bbs2-0103" title="World Health Organization (WHO). Draft landscape of COVID-19 candidate vaccines. www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines (accessed 15 April 2021).">WHO 2021d</a>). However, the process is time‐consuming, and global access to vaccines differs widely (<a href="./references#CD015061-bbs2-0106" title="WoutersOJ , ShadlenKC , Salcher-KonradM , PollardAJ , LarsonHJ , TeerawattananonY , et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet2021;10278:1023-34. [DOI: 10.1016/S0140-6736(21)00306-8]">Wouters 2021</a>). Moreover, the degree to which the vaccines can protect against variants of SARS‐CoV‐2 was still unclear at the date of publication (<a href="./references#CD015061-bbs2-0047" title="Forni G,  Mantovani A. COVID-19 vaccines: where we stand and challenges ahead. Cell Death &amp; Differentiation2021;28:626-39. [DOI: 10.1038/s41418-020-00720-9]">Forni 2021</a>).  </p> <p>Specific risk factors for severe disease, hospitalization, and mortality have been identified: individuals aged 65 years or older, smokers, and those with certain underlying medical conditions, such as cancer, chronic kidney disease, chronic obstructive pulmonary disease (COPD), heart conditions, immunocompromised state, obesity, sickle cell disease, or diabetes mellitus are more likely to have a severe course of the disease (<a href="./references#CD015061-bbs2-0053" title="HuangC , WangY , LiX , RenL , ZhaoJ , HuY , et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet2020;395(10223):497-506. [DOI: 10.1016/S0140-6736(20)30183-5]">Huang 2020</a>; <a href="./references#CD015061-bbs2-0062" title="LiangW , GuanW , ChenR , WangW , LiJ , XuK , et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet2020;21(3):335-7. [DOI: 10.1016/S1470-2045(20)30096-6]">Liang 2020</a>; <a href="./references#CD015061-bbs2-0097" title="World Health Organization (WHO). Report of the WHO‐China Joint Mission on coronavirus disease 2019 (COVID‐19). www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report (accessed prior to 9 August 2021).">WHO 2020a</a>; <a href="./references#CD015061-bbs2-0105" title="WilliamsonE , WalkerAJ , BhaskaranKJ , BaconS , BatesC , MortonCE , et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature2020;584:430-6. [DOI: 10.1038/s41586-020-2521-4]">Williamson 2020</a>). COVID‐19 case fatality varies widely between countries and reporting periods (from 1% to more than 19%; <a href="./references#CD015061-bbs2-0055" title="Johns Hopkins University of Medicine Coronavirus Resource Center. Mortality analyses. coronavirus.jhu.edu/data/mortality (accessed 16 April 2021).">Johns Hopkins 2021</a>). However, these numbers may be misleading due to varying testing frequency, lag in reporting dates, incomplete capturing of all cases, and variations in case definitions since the beginning of the pandemic (<a href="./references#CD015061-bbs2-0098" title="World Health Organization (WHO). Estimating mortality from COVID-19—scientific brief. www.who.int/publications/i/item/WHO-2019-nCoV-Sci-Brief-Mortality-2020.1 (accessed 2 November 2020).">WHO 2020b</a>).  </p> <p>Sore throat, cough, fever, headache, fatigue, and myalgia or arthralgia are the most commonly reported symptoms (<a href="./references#CD015061-bbs2-0087" title="StruyfT , DeeksJJ , DinnesJ , TakwoingiY , DavenportC , LeeflangMM , et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database of Systematic Reviews2020, Issue 7. Art. No: CD013665. [DOI: 10.1002/14651858.CD013665]">Struyf 2020</a>). Other symptoms include dyspnea, chills, nausea or vomiting, diarrhea, loss of taste and smell, and nasal congestion (<a href="./references#CD015061-bbs2-0097" title="World Health Organization (WHO). Report of the WHO‐China Joint Mission on coronavirus disease 2019 (COVID‐19). www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report (accessed prior to 9 August 2021).">WHO 2020a</a>). The majority of people infected at the beginning of the pandemic had mild symptoms (approximately 80%, <a href="./references#CD015061-bbs2-0107" title="WuZ , McGooganJM . Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA2020;323(13):1239-42. [DOI: 10.1001/jama.2020.2648]">Wu 2020</a>), or remained completely asymptomatic (<a href="./references#CD015061-bbs2-0040" title="Buitrago-GarciaD , Egli-GanyD , CounotteMJ , HossmannS , ImeriH , Ipekci AzizM , et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLOS Medicine2020;17(9):e1003346. [DOI: 10.1371/journal.pmed.1003346]">Buitrago‐Garcia 2020</a>). Early data from China show that a smaller proportion (approximately 14%) are affected by severe or critical disease with intensive care unit (ICU) admittance due to respiratory failure, septic shock, or multiple organ dysfunction (<a href="./references#CD015061-bbs2-0107" title="WuZ , McGooganJM . Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA2020;323(13):1239-42. [DOI: 10.1001/jama.2020.2648]">Wu 2020</a>).  </p> <p>At the time of the writing of this review, treatment consisted of supportive care with extracorporeal membrane oxygenation (ECMO), invasive ventilation, and non‐invasive ventilation in severe cases, and oxygen supply in moderately severe cases (<a href="./references#CD015061-bbs2-0102" title="World Health Organization (WHO). COVID-19 Clinical management: living guidance. www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1 (accessed 15 April 2021).">WHO 2021c</a>). Few drugs were approved for the treatment of COVID‐19, such as corticosteroids, monoclonal antibodies, or convalescent plasma. Recommendations for the use of corticosteroids, <a href="./references#CD015061-bbs2-0084" title="SiemieniukR , RochwergB , AgoritsasT , LamontagneF , LeoYS , MacdonaldH , et al. A living WHO guideline on drugs for covid-19. BMJ2020;370:m3379. [DOI: 10.1136/bmj.m3379]">Siemieniuk 2020</a>, and tocilizumab, <a href="./references#CD015061-bbs2-0089" title="TaskforceNCCE . Clinical Care Guidance. covid19evidence.net.au/ (accessed prior to 9 August 2021).">Taskforce NCCE 2021</a>; <a href="./references#CD015061-bbs2-0104" title="World Health Organization (WHO). Therapeutics and COVID-19: living guideline. Version 6.1. app.magicapp.org/#/guideline/nBkO1E (accessed 15 July 2021).">WHO 2021e</a>, were given in clinical guidelines, but only for patients with severe or critical COVID‐19 infection receiving oxygen. Other drugs, such as ivermectin and hydroxychloroquine, were not recommended for the treatment of COVID‐19 at the point of review publication (<a href="./references#CD015061-bbs2-0104" title="World Health Organization (WHO). Therapeutics and COVID-19: living guideline. Version 6.1. app.magicapp.org/#/guideline/nBkO1E (accessed 15 July 2021).">WHO 2021e</a>). Guidelines for symptom control (e.g. dyspnea) were mostly informed by studies of cancer patients and patients with COPD (<a href="./references#CD015061-bbs2-0036" title="Barnes H, McDonald J, Smallwood N, Manser R. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database of Systematic Reviews2016, Issue 3. Art. No: CD011008. [DOI: 10.1002/14651858.CD011008]">Barnes 2016</a>). As the course of COVID‐19 is quite different from these diseases with respect to the rapid onset of symptoms (e.g. dyspnea) and the underlying cause of symptoms, evidence on interventions in COVID‐19 patients is needed. </p> <p>In light of evolving variants of the virus with increased transmissibility and possibly higher mortality (<a href="./references#CD015061-bbs2-0042" title="Challen R,  Brooks-Pollock E,  Read JM,  Dyson L,  Tsaneva-Atanasova K,  Danon L. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study. BMJ2021;327(n579):1-10. [DOI: 10.1136/bmj.n579]">Challen 2021</a>), the number of COVID‐19‐associated deaths might increase the need for adequate symptom control in a palliative situation. Moreover, we do not know if the needs of patients with COVID‐19 will change with the appearance of new variants. The most prevalent symptoms in hospitalized patients with COVID‐19 are dyspnea, cough, fatigue, myalgia (muscle pain), and delirium, with dyspnea being the most significant symptom in the dying (<a href="./references#CD015061-bbs2-0057" title="KeeleyP , BuchananD , CarolanC , PivodicL , TavabieS , NobleS . Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary. BMJ Supportive &amp; Palliative Care2020;10(4):381-4. [DOI: 10.1136/bmjspcare-2020-002368]">Keeley 2020</a>). Delirium might be more prevalent in patients suffering from COVID‐19 when compared to other diseases (<a href="./references#CD015061-bbs2-0037" title="BarronEA , HolmesJ . Delirium within the emergency care setting, occurrence and detection: a systematic review. Emergency Medicine Journal2013;30(4):263-8. [DOI: 10.1136/emermed-2011-200586]">Barron 2012</a>; <a href="./references#CD015061-bbs2-0058" title="KennedyM , HelfandBKI , GouRY , GartaganisSL , WebbM , MocciaJM , et al. Delirium in older patients with COVID-19 presenting to the emergency department. JAMA Network Open2020;3(11):e2029540. [DOI: 10.1001/jamanetworkopen]">Kennedy 2020</a>). Especially in the dying, multimodal (pharmacological and non‐pharmacological) interventions are needed to alleviate symptoms and thus achieve best possible quality of life. If possible, these interventions should be provided by multiprofessional palliative care teams, but also by all other disciplines, such as intensive care or general medicine.  </p> </section> <section id="CD015061-sec-0011"> <h3 class="title" id="CD015061-sec-0011">Description of the intervention</h3> <p>According to a recent consensus‐based definition, palliative care is "the active holistic care of individuals across all ages with serious health‐related suffering due to severe illness and especially of those near the end of life (<a href="./references#CD015061-bbs2-0077" title="RadbruchL , De LimaL , KnaulF , WenkR , AliZ , BhatnagharS , et al. Redefining palliative care—a new consensus-based definition. Journal of Pain and Symptom Management2020;60(4):754-64. [DOI: 10.1016/j.jpainsymman.2020.04.027]">Radbruch 2020</a>)." Adequate palliative symptom control can significantly improve the quality of life for individuals and their families. This is considered in the <a href="./references#CD015061-bbs2-0099" title="World Health Organization (WHO). Palliative care. www.who.int/news-room/fact-sheets/detail/palliative-care (accessed 13 July 2021).">WHO 2020c</a> definition of palliative care: "Palliative care is an approach that improves the quality of life of patients and their families facing the problems associated with life‐threatening illness, through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems, physical, psychosocial and spiritual." COVID‐19 may be incurable or curable, and the treatment goals for these patients may change within hours. Based on the definition of palliative care by <a href="./references#CD015061-bbs2-0077" title="RadbruchL , De LimaL , KnaulF , WenkR , AliZ , BhatnagharS , et al. Redefining palliative care—a new consensus-based definition. Journal of Pain and Symptom Management2020;60(4):754-64. [DOI: 10.1016/j.jpainsymman.2020.04.027]">Radbruch 2020</a>, we only included studies for patients “near the end of life,” and excluded studies addressing patients with curative treatment goals. We define “palliative symptom control” as palliative (not curative) interventions that aim at amelioration of symptoms in advanced COVID‐19.  </p> <p>Palliative symptom control utilizes both pharmacological and non‐pharmacological interventions, which are often provided by multiprofessional teams. At present, it is unclear which specific palliative interventions should be used for symptom control for individuals with COVID‐19. </p> <p>Pharmacological interventions might include the use of opioids and second‐line benzodiazepines for the relief of dyspnea, or antipsychotics to alleviate symptoms of delirium (<a href="./references#CD015061-bbs2-0070" title="Mottiar M, Hendin A, FischerL , des Ordons AR,  Hartwick M. End-of-life care in patients with a highly transmissible respiratory virus: implications for COVID-19. Canadian Journal of Anaesthesia2020;67:1-7. [DOI: 10.1007/s12630-020-01699-0]">Mottiar 2020</a>). Anticholinergics are used in the dying to reduce airway secretions ('death rattle') (<a href="./references#CD015061-bbs2-0067" title="MercadamteS . Death rattle: critical review and research agenda. Support Care Cancer2014;22(2):571-5. [DOI: 10.1007/s00520-013-2047-5]">Mercadamte 2014</a>). Non‐pharmacological interventions include alternative interventions (e.g. Traditional Chinese Medicine) and psychological support, but also measures such as the discontinuation of interventions (<a href="./references#CD015061-bbs2-0070" title="Mottiar M, Hendin A, FischerL , des Ordons AR,  Hartwick M. End-of-life care in patients with a highly transmissible respiratory virus: implications for COVID-19. Canadian Journal of Anaesthesia2020;67:1-7. [DOI: 10.1007/s12630-020-01699-0]">Mottiar 2020</a>). Non‐pharmacological interventions can be a prelude to pharmacological interventions or can be used alongside pharmacological treatments. Even though research on symptom control is scarce, the National Institute for Health and Care Excellence (NICE) has published consensus‐based guidelines for managing COVID‐19‐associated symptoms at the end of life (<a href="./references#CD015061-bbs2-0073" title="National Institute for Health and Care Excellence (NICE). Managing COVID-19 symptoms (including at the end of life) in the community: summary of NICE guidelines. BMJ2020;369:m1461. [DOI: 10.1136/bmj.m1461]">NICE 2020</a>). For example, pharmacological treatments such as codeine linctus, codeine phosphate tablets, or morphine sulfate oral solution are recommended to treat breathlessness and cough; non‐pharmacological treatments include controlled breathing techniques. </p> <p>Palliative care interventions provided by palliative care teams decrease symptom intensity and improve quality of life among individuals with advanced cancer compared to standard cancer care alone (<a href="./references#CD015061-bbs2-0048" title="Gaertner J,  Siemens W,  Meerpohl JJ,  Antes G,  Meffert C,  Xander C, et al. Effect of specialist palliative care services on quality of life in adults with advanced incurable illness in hospital, hospice, or community settings: systematic review and meta-analysis. BMJ2017;375:1-14. [DOI: 10.1136/bmj.j2925]">Gaertner 2017</a>; <a href="./references#CD015061-bbs2-0050" title="Haun MW, Estel S, Rücker G, Friederich HC, Villalobos M, Thomas M, et al. Early palliative care for adults with advanced cancer. Cochrane Database of Systematic Reviews2017, Issue 6. Art. No: CD011129. [DOI: 10.1002/14651858.CD011129.pub2]">Haun 2017</a>). Similiar positive outcomes can be expected in COVID‐19 patients if treated by palliative care teams. </p> </section> <section id="CD015061-sec-0012"> <h3 class="title" id="CD015061-sec-0012">How the intervention might work</h3> <p>The subjective perception of dyspnea, the difficulty to breathe, can appear without hypoxia or hypercapnia, but may be mediated via blood gas abnormalities (increase of partial pressure of carbon dioxide, decrease of oxygen, or both), detected by central chemoreceptors and processed in the respiratory center in the medulla and by cortical structures (<a href="./references#CD015061-bbs2-0039" title="BuchananGF , RichersonGB . Role of chemoreceptors in mediating dyspnea. Respiratory Physiology and Neurobiology2008;176(1):9-19. [DOI: 10.1016/j.resp.2008.12.002]">Buchanan 2009</a>). Furthermore, the muscular respiratory effort, as well as emotional, social, and psychological factors may significantly contribute to the sensation of dyspnea (<a href="./references#CD015061-bbs2-0044" title="CrombeenAM , LillyEJ . Management of dyspnea in palliative care. Current Oncology2020;27(3):142-5. [DOI: 10.3747/co.27.6413.]">Crombeen 2020</a>; <a href="./references#CD015061-bbs2-0094" title="vonLeupoldtA , DahmeB . Psychological aspects in the perception of dyspnea in obstructive pulmonary diseases. Respiratory Medicine2007;101(3):411-22. [DOI: 10.1016/j.rmed.2006.06.011]">von Leupoldt 2007</a>). Endogenous opioids may modulate breathlessness perception to be less unpleasant (<a href="./references#CD015061-bbs2-0056" title="JohnsonMJ , CurrowDC . Opioids for breathlessness: a narrative review. BMJ Supportive &amp; Palliative Care2020;10:287-95. [DOI: 10.1136/bmjspcare-2020-002314]">Johnson 2020</a>; <a href="./references#CD015061-bbs2-0064" title="MahlerDA , GiffordAH , WatermanLA , WardJ , KraemerWJ , KupchakBR , et al. Effect of increased blood levels of β-endorphin on perception of breathlessness. Chest2013;143(5):1378-85. [DOI: 10.1378/chest.12-1541]">Mahler 2013</a>). Opioids may alleviate dyspnea via an altered response of the central nervous system to blood gas changes, resulting in a reduction of the respiratory drive (<a href="./references#CD015061-bbs2-0035" title="BanzettRB , MulnierHE , MurphyK , RosenSD , WiseRJ , AdamsL . Breathlessness in humans activates insular cortex. Neuroreport2000;11(10):2117-20. [DOI: 10.1097/00001756-200007140-00012]">Banzett 2000</a>; <a href="./references#CD015061-bbs2-0076" title="PattinsonKT , GovernoRJ , MacIntoshBJ , RussellEC , CorfieldDR , TraceyI , et al. Opioids depress cortical centers responsible for the volitional control of respiration. Journal of Neuroscience2009;29(25):8177-86. [DOI: 10.1523/JNEUROSCI.1375-09.2009]">Pattinson 2009</a>). Opioid‐induced pain reduction and sedation decrease oxygen demand and carbon dioxide production. Benzodiazepines induce anxiolytic, sedative, and anti‐agitative effects by gamma‐aminobutyric acid (GABA)‐receptor modulation (<a href="./references#CD015061-bbs2-0049" title="Griffin CE 3rd, KayeAM , BuenoFR , KayeAD . Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner Journal2013;13(2):214-23. [PMID: 23789008]">Griffin 2013</a>). Antipsychotics (neuroleptics) for treatment of (terminal) delirium may act through antagonism at the dopamine (D2)‐receptor (<a href="./references#CD015061-bbs2-0054" title="HuiD , De La RosaA , WilsonA , NguyenT , WuJ , Delgado-GuayM , et al. Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial. Lancet Oncology2020;21(7):989-98. [DOI: 10.1016/S1470-2045(20)30307-7]">Hui 2020</a>; <a href="./references#CD015061-bbs2-0066" title="MeagherD , AgarMR , TeodorczukA . Debate article: Antipsychotic medications are clinically useful for the treatment of delirium. International Journal of Geriatric Psychiatry2018;33:1420-7. [DOI: 10.1002/gps.4759]">Meagher 2018</a>). Anticholinergics may reduce 'death rattle' through reducing airway secretions (<a href="./references#CD015061-bbs2-0067" title="MercadamteS . Death rattle: critical review and research agenda. Support Care Cancer2014;22(2):571-5. [DOI: 10.1007/s00520-013-2047-5]">Mercadamte 2014</a>). Non‐pharmacological interventions include psychological interventions (e.g. relaxation, imagination practices, controlled breathing techniques). They have beneficial effects on dyspnea through the reduction of tachypnea (<a href="./references#CD015061-bbs2-0094" title="vonLeupoldtA , DahmeB . Psychological aspects in the perception of dyspnea in obstructive pulmonary diseases. Respiratory Medicine2007;101(3):411-22. [DOI: 10.1016/j.rmed.2006.06.011]">von Leupoldt 2007</a>). </p> </section> <section id="CD015061-sec-0013"> <h3 class="title" id="CD015061-sec-0013">Why it is important to do this review</h3> <p>There is a clear, urgent need for more information to guide symptom control and end‐of‐life care in people with COVID‐19. Management of the symptoms most frequently encountered in COVID‐19 patients, such as dyspnea, cough, fatigue, myalgia and agitation and delirium, is a central component of palliative care and reduces suffering at the end of life. Adequate symptom relief is therefore of utmost importance for patients, but also for relatives, and loved ones. Importantly, palliative care in the context of a pandemic poses new challenges, as the care has to be delivered in a quarantined context and often without families visiting the patient. Various recommendations for the control of these symptoms have been made in expert opinion statements by professional societies (<a href="./references#CD015061-bbs2-0072" title="NehlsW , DelisS , HaberlandB , MaierBO , SängerK , TessmerG , et al. Management of patients with COVID-19—recommendations from a palliative care perspective. Pneumologie2020;774(10):652-9. [DOI: 10.1055/a-1156-2759]">Nehls 2020</a>; <a href="./references#CD015061-bbs2-0073" title="National Institute for Health and Care Excellence (NICE). Managing COVID-19 symptoms (including at the end of life) in the community: summary of NICE guidelines. BMJ2020;369:m1461. [DOI: 10.1136/bmj.m1461]">NICE 2020</a>). In addition, the first studies investigating symptom control in COVID‐19 have been published. A systematic review and subsequent update of the available literature is needed to inform recommendations for action on symptom control of COVID‐19 in the palliative setting.  </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD015061-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD015061-sec-0014"></div> <p>To assess the efficacy and safety of pharmacological and non‐pharmacological interventions for palliative symptom control in individuals with COVID‐19. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD015061-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD015061-sec-0015"></div> <section id="CD015061-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD015061-sec-0017"> <h4 class="title">Types of studies</h4> <p>The main description of methods is based on the template for intervention reviews with non‐randomized studies of the Cochrane Haematology review group. The protocol for this review was registered with the international prospective register of systematic reviews (PROSPERO) (<a href="./references#CD015061-bbs2-0108" title="AndreasM , PiechottaV , BeckerG , Metzendorf M-I, SkoetzN , MeissnerW , et al. Palliative symptom management in Covid-19 patients: a systematic review. PROSPERO. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021233630. 2021.">Andreas 2021</a>). </p> <p>We planned to include randomized controlled trials (RCTs), and, if these were not available, the following types of studies in a top‐down approach: quasi‐RCTs, controlled clinical trials, controlled before‐after studies, interrupted time series (with comparison group), prospective cohort studies, retrospective cohort studies, (nested) case‐control studies, and cross‐sectional studies. </p> <p>As planned at the protocol stage, we included non‐comparative study designs because we did not expect any evidence from RCTs. Randomized controlled studies are challenging in the palliative care setting for multiple reasons. For example, using placebo (or other) controls might not be ethically justifiable, as it could lead to unnecessary suffering at the end of life. Furthermore, dying people are often unable to consent to studies, and consent by proxy is complicated by the grief of the relatives. Especially in the field of palliative care, such issues are of major importance, because the vulnerable population and the unstable nature of the underlying diseases are associated with unexpected recruitment and attrition problems that demand the conduction of thoroughly performed feasibility trials (<a href="./references#CD015061-bbs2-0083" title="Shelby-JamesTM , HardyJ , AgarM , YatesP , MitchellG , SandersonC , et al. Designing and conducting randomized controlled trials in palliative care: a summary of discussions from the 2010 clinical research forum of the Australian Palliative Care Clinical Studies Collaborative. Palliative Medicine2012;26(8):1042-7. [DOI: 10.1177/0269216311417036]">Shelby‐James 2012</a>).  </p> <p>We thus do not expect that any RCTs on this topic will be published soon. One controlled study investigating the effectiveness of morphine in the treatment of dyspnea in COVID‐19 is currently being conducted (<a href="./references#CD015061-bbs2-0032" title="NCT04522037. Measurement of the efficacy of morphine in the early management of dyspnea in COVID-19 positive patients (CODYS). clinicaltrials.gov/ct2/show/NCT04522037 (first received 21 August 2020). ">NCT04522037</a>). However, information on the most effective symptom control in individuals with COVID‐19 is acutely needed. For this reason, we decided to also include non‐controlled studies. </p> <p>We included studies with one or more participant(s) with COVID‐19. We followed the suggestions specified in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> to the greatest degree possible and applied the methodology outlined in the following sections of this review (<a href="./references#CD015061-bbs2-0052" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>). Further information on the methods we had planned should we have identified RCTs or non‐randomized studies of interventions (NRSIs) is provided in <a href="./appendices#CD015061-sec-0096">Appendix 1</a>. </p> <p>We included full‐text publications, preprints, abstract publications, results published in trials registries, and information received from personal communication with investigators if sufficient information was available on study design, characteristics of participants, interventions, and outcomes. We did not apply any limitations with respect to study setting (home‐based, hospital, hospices, or nursing homes). </p> </section> <section id="CD015061-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included individuals with a confirmed diagnosis of COVID‐19 receiving interventions for palliative symptom control with no restrictions regarding comorbidities, age, gender, or ethnicity.  </p> <p>We excluded studies evaluating palliative interventions for symptoms caused by other terminal illnesses. If studies enrolled populations with or exposed to diseases, we would only include such studies if the authors provided subgroup data for SARS‐CoV‐2 infection. We excluded studies investigating interventions for symptom control in a curative setting, for example patients receiving life‐prolonging therapies such as invasive ventilation.  </p> </section> <section id="CD015061-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We defined 'palliative symptom control' as palliative (not curative) interventions that aim to ameliorate symptoms in advanced COVID‐19. We included the following interventions: palliative symptom control as a multidimensional and holistic approach, including: </p> <p> <ul id="CD015061-list-0001"> <li> <p>pharmacological interventions (including but not limited to opioids, benzodiazepines, neuroleptics, and anticholinergics); </p> </li> <li> <p>non‐pharmacological interventions (including but not limited to acupressure, music therapy,  physical therapy, distraction, breathing techniques, and relaxation). </p> </li> </ul> </p> <p>In future updates, we plan to include the following comparisons for studies with a control arm: </p> <p> <ul id="CD015061-list-0002"> <li> <p>pharmacological intervention A (e.g. opioids) versus pharmacological intervention B or placebo for symptom control of dyspnea, cough, agitation/delirium; </p> </li> <li> <p>specialized palliative care versus standard care (specialized palliative care is given by specialized palliative care teams (e.g. palliative care consultation services in hospitals) in contrast to general palliative care (e.g. given by general practitioners)). </p> </li> </ul> </p> </section> <section id="CD015061-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>We planned to evaluate the following outcomes.</p> <section id="CD015061-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD015061-list-0003"> <li> <p>Symptom relief, comprising any change of subjective and potentially burdensome symptoms like dyspnea/shortness of breath, cough, anxiety, agitation, fatigue, myalgia, and delirium between baseline measurement before intervention and after intervention, measured with validated patient‐reported outcome measures (e.g. visual analogue scale (VAS)), or other standardized instruments reported by patients, family members, or caregivers. </p> </li> </ul> </p> </section> <section id="CD015061-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD015061-list-0004"> <li> <p>Quality of life, including fatigue and neurological functions, assessed with standardized scales (e.g. European Organisation for Research and Treatment of Cancer (EORTC), McGill Quality of Life Questionnaire). </p> </li> <li> <p>Symptom burden (e.g. distress thermometer, IPOS).</p> </li> <li> <p>Satisfaction of patients.</p> </li> <li> <p>Satisfaction of caregivers and relatives.</p> </li> <li> <p>Serious adverse events, defined as number of participants with event.</p> </li> <li> <p>Grade 3 to 4 adverse events, defined as number of participants with event. </p> </li> </ul> </p> </section> </section> </section> <section id="CD015061-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD015061-sec-0024"> <h4 class="title">Electronic searches</h4> <p>For the identification of studies on interventions for palliative symptom control of COVID‐19, we designed search strategies in accordance with the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD015061-bbs2-0060" title="LefebvreC , GlanvilleJ , BriscoeS , LittlewoodA , MarshallC , Metzendorf M-I, et al. Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Lefebvre 2021</a>). KG developed the search strategy based on input by clinicians. The search strategy was peer‐reviewed by two Information Specialists experienced in the terminologies used in COVID‐19 research (Ina Monsef and Maria‐Inti Metzendorf). Due to the international urgency for research on COVID‐19, we assumed that the abstracts of clinical trials would have been published in English. If the full‐text publication was published in a language outside the abilities of our team, we would have involved Cochrane Task Exchange to identify people who were able to translate (<a href="https://taskexchange.cochrane.org/" target="_blank">taskexchange.cochrane.org</a>). </p> <section id="CD015061-sec-0025"> <h5 class="title">Searches for evidence synthesis</h5> <p>We initially conducted a search for existing or planned evidence synthesis in the following sources. </p> <section id="CD015061-sec-0026"> <h6 class="title">Manual search</h6> <p> <ul id="CD015061-list-0005"> <li> <p>Evidence Aid Coronavirus (COVID‐19) (<a href="https://evidenceaid.org/evidence/coronavirus-covid-19/" target="_blank">evidenceaid.org/evidence/coronavirus-covid-19/</a>) </p> </li> <li> <p>Coronavirus (COVID‐19) (the Cochrane Library) (<a href="https://www.cochranelibrary.com/covid-19" target="_blank">www.cochranelibrary.com/covid-19</a>) including Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (PubMed), Embase, ClinicalTrials.gov, World Health Organization International Clinical Trials Registry Platform (WHO ICTRP), medRxiv </p> </li> <li> <p>Usher Network for COVID‐19 Evidence Reviews (<a href="https://www.ed.ac.uk/usher/uncover/register-of-reviews" target="_blank">www.ed.ac.uk/usher/uncover</a>) </p> </li> <li> <p>US Department of Veterans Affairs Evidence Synthesis Program (<a href="http://www.covid19reviews.org/" target="_blank">www.hsrd.research.va.gov/publications/esp/</a>) </p> </li> <li> <p>Australian guidelines for the clinical care of people with COVID‐19 (<a href="https://covid19evidence.net.au/#living-guidelines" target="_blank">https://files.magicapp.org/guideline/8b6f065b-814f-41f0-a1a5-70279b722e19/published_guideline_4346-12_0.pdf</a>) </p> </li> <li> <p>Norwegian Institute of Public Health systematic and living map on COVID‐19 evidence (<a href="https://www.nornesk.no/forskningskart/NIPH_mainMap.html" target="_blank">www.fhi.no/en/qk/systematic-reviews-hta/map/</a>) </p> </li> <li> <p>COVID‐19 Evidence Alerts from McMaster PLUS (<a href="https://plus.mcmaster.ca/COVID-19" target="_blank">www.evidencealerts.com/</a>) </p> </li> <li> <p>L*OVE (<a href="https://app.iloveevidence.com/loves/5e6fdb9669c00e4ac072701d?utm=aile" target="_blank">iloveevidence.com/</a>) </p> </li> <li> <p>TRIP (<a href="https://www.tripdatabase.com" target="_blank">www.tripdatabase.com/</a>) </p> </li> <li> <p>ECRI COVID‐19 Resource Center (<a href="https://www.ecri.org/covid-19-clinical-evidence-assessments" target="_blank">www.ecri.org/coronavirus-covid-19-outbreak-preparedness-center/</a>) </p> </li> <li> <p>JBI Evidence Synthesis COVID‐19 Collection (<a href="https://journals.lww.com/jbisrir/pages/collectiondetails.aspx?TopicalCollectionId=15" target="_blank">jbi.global/covid-19</a>) </p> </li> <li> <p>NICE Coronavirus (COVID‐19) (<a href="https://www.nice.org.uk/guidance/conditions-and-diseases/respiratory-conditions/covid19" target="_blank">www.nice.org.uk/guidance/conditions-and-diseases/respiratory-conditions/covid19</a>) </p> </li> </ul> </p> </section> <section id="CD015061-sec-0027"> <h6 class="title">Database search</h6> <p> <ul id="CD015061-list-0006"> <li> <p>MEDLINE (Ovid) </p> </li> </ul> </p> </section> <section id="CD015061-sec-0028"> <h6 class="title">Manual search (planned evidence synthesis)</h6> <p> <ul id="CD015061-list-0007"> <li> <p>Oxford COVID‐19 Evidence Service—Current questions under review (<a href="https://www.cebm.net/oxford-covid-19-evidence-service/" target="_blank">www.cebm.net/oxford-covid-19-evidence-service/</a>) </p> </li> <li> <p>Cochrane COVID Review Bank (<a href="https://covidreviews.cochrane.org/search/site" target="_blank">covidreviews.cochrane.org/search/site</a>) </p> </li> <li> <p>PROSPERO (<a href="https://www.crd.york.ac.uk/prospero/" target="_blank">www.crd.york.ac.uk/prospero/</a>) </p> </li> </ul> </p> <p>These initial searches were conducted on 27 November 2020. The search strategies are documented in <a href="./appendices#CD015061-sec-0112">Appendix 2</a>, <a href="./appendices#CD015061-sec-0113">Appendix 3</a>, and <a href="./appendices#CD015061-sec-0114">Appendix 4</a>. </p> </section> </section> <section id="CD015061-sec-0029"> <h5 class="title">Searches for primary studies</h5> <p>We searched the following databases and trials registries for primary studies without any language limits, initially on 8 January 2021 and updated on 23 March 2021. </p> <p> <ul id="CD015061-list-0008"> <li> <p>Cochrane COVID‐19 Study Register (<a href="https://covid-19.cochrane.org/" target="_blank">covid-19.cochrane.org/</a>) </p> </li> <li> <p>Web of Science<b> </b>(Science Citation Index/Emerging Sources) </p> </li> <li> <p>CINAHL (via EBSCO) (Cumulative Index to Nursing and Allied Health Literature)</p> </li> <li> <p>World Health Organization COVID‐19 Global literature on coronavirus disease (<a href="https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/" target="_blank">search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/</a>) </p> </li> <li> <p>COAP Living Evidence on COVID‐19 (<a href="https://zika.ispm.unibe.ch/assets/data/pub/search_beta/" target="_blank">zika.ispm.unibe.ch/assets/data/pub/search_beta/</a>) </p> </li> </ul> </p> <p>The search strategies are documented in <a href="./appendices#CD015061-sec-0112">Appendix 2</a>, <a href="./appendices#CD015061-sec-0113">Appendix 3</a>, and <a href="./appendices#CD015061-sec-0115">Appendix 5</a>. </p> <p>If results were uploaded into trials registries and had not yet been published elsewhere, we integrated these data for the current review, and will add or replace data in future updates of this review in the case of publication. </p> </section> </section> <section id="CD015061-sec-0030"> <h4 class="title">Searching other resources</h4> <p>We handsearched reference lists of any included articles in order to identify any further relevant studies.  </p> <p>We checked the reference lists of all identified studies and relevant review articles identified by an additional literature search (the initial search) and current treatment guidelines for further literature. Please see <a href="./appendices#CD015061-sec-0114">Appendix 4</a> for additional information on our strategy.  </p> </section> </section> <section id="CD015061-sec-0031"> <h3 class="title" id="CD015061-sec-0031">Data collection and analysis</h3> <section id="CD015061-sec-0032"> <h4 class="title">Selection of studies</h4> <p>Three members of the review team (MA, CB, and LJ) independently screened the results of the search for eligibility by reading the abstracts. We coded the abstracts as either 'include' or 'exclude' using the software Rayyan (<a href="./references#CD015061-bbs2-0074" title="OuzzaniM , HammadyH , FedorowiczZ , Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Systematic Reviews2016;5(1):210. [DOI: 10.1186/s13643-016-0384-4]">Ouzzani 2016</a>). In the case of disagreement, or if it was unclear whether we should retrieve the abstract or not, we obtained the full‐text publication for further discussion. Two review authors (MA and CB) assessed the full‐text articles of selected studies. In case of disagreement, a third review author (VP) was consulted to reach a final decision. </p> <p>We documented the study selection process in a flow chart, as recommended in the PRISMA statement (<a href="./references#CD015061-bbs2-0069" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Journal of Clinical Epidemiology2009;62(10):1006-12.">Moher 2009</a>), and show the total numbers of retrieved references and the numbers of included and excluded studies (see <a href="#CD015061-fig-0001">Figure 1</a>). Articles excluded after full‐text assessment and the reasons for their exclusions are provided in <a href="./references#CD015061-sec-0128" title="">Characteristics of excluded studies</a>.  </p> <div class="figure" id="CD015061-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD015061-fig-0001" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD015061-sec-0033"> <h4 class="title">Data extraction and management</h4> <p>We conducted data extraction and assessments according to the guidelines proposed by Cochrane (<a href="./references#CD015061-bbs2-0061" title="LiT , HigginsJPT , DeeksJJ . Chapter 5: Collecting data. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Li 2021</a>). Two out of three review authors (MA, MB, and CB) performed all data extraction and assessments. Two other review authors (VP and WM) verified the accuracy and (where applicable) the plausibility of data extraction and assessments. We collated multiple reports of one study so that each study, rather than each report, was the unit of analysis. We extracted data using a customized data extraction form developed in Microsoft Excel (<a href="./references#CD015061-bbs2-0068" title="Excel. Microsoft Corporation. Microsoft Corporation, 2018. Available at office.microsoft.com/excel.">Microsoft 2018</a>), and extracted the following information. </p> <p> <ul id="CD015061-list-0009"> <li> <p>General information: author, title, source, publication date, and country.</p> </li> <li> <p>Quality assessment and risk of bias: study design, confounding, selection bias, attrition bias, detection bias, and reporting bias. </p> </li> <li> <p>Study characteristics: study design, setting, and dates, source of participants, inclusion/exclusion criteria, comparability of groups, compliance with assigned treatment, and length of follow‐up. </p> </li> <li> <p>Participant characteristics: age, gender, number of participants recruited/allocated/evaluated, disease, severity of disease, comorbidity, prevalence of symptoms and treated symptoms. </p> </li> <li> <p>Interventions: pharmacological and non‐pharmacological treatment and mode of drug delivery. </p> </li> <li> <p>Outcomes: as specified in <a href="#CD015061-sec-0020">Types of outcome measures</a>. </p> </li> </ul> </p> </section> <section id="CD015061-sec-0034"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We planned that if RCT data were available, we would use the RoB 2 tool to analyze the risk of bias in the underlying study results (<a href="./references#CD015061-bbs2-0086" title="SterneJAC , SavovicJ , PageMJ , ElbersRG , BlencoweNS , BoutronI , et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ2019;366(l4898):1-8. [DOI: 10.1136/bmj.l4898]">Sterne 2019</a>). If NRSI data were available, we would use the Risk Of Bias In Non‐randomised Studies—of Interventions (ROBINS‐I) tool (<a href="./references#CD015061-bbs2-0085" title="SterneJA , HernánMA , ReevesBC , SavovićJ , BerkmanND , ViswanathanM , et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ2016;355:1-7. [DOI: 10.1136/bmj.i4919]">Sterne 2016</a>). Detailed information on how we had planned to assess risk of bias of RCTs and NRSIs is provided in <a href="./appendices#CD015061-sec-0096">Appendix 1</a>. </p> <p>To assess risk of bias in uncontrolled studies, we used a modified version of the Newcastle Ottawa Scale, provided by <a href="./references#CD015061-bbs2-0071" title="MulderRL , BrestersD , Van den HofM , KootBG , CastellinoSM , LokeYK , et al. Hepatic late adverse effects after antineoplastic treatment for childhood cancer. Cochrane Database of Systematic Reviews2019, Issue 4. Art. No: CD008205. [DOI: 10.1002/14651858.CD008205.pub3]">Mulder 2019</a>.  </p> <p>As specified in <a href="#CD015061-sec-0017">Types of studies</a>, we included uncontrolled studies only when we were unable to identify controlled studies. </p> <p>Two review authors (MA and CB) assessed the included studies for methodological quality and risk of bias in accordance with the criteria outlined below and in <a href="#CD015061-tbl-0002">Table 1</a>. Any disagreements regarding the quality assessments were resolved by discussion, and two review authors (VP and WM) verified the accuracy and the plausibility of assessments. We performed and presented our judgements per outcome per study. </p> <div class="table" id="CD015061-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Risk of bias assessment criteria for observational studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Internal validity</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>External validity</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study group</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Selection bias</b> (unrepresentative study group)<br/>  </p> <p>The study group was considered representative,</p> <p> <ul id="CD015061-list-0010"> <li> <p>if the described study group consisted of &gt; 80% of individuals with COVID‐19 treated with palliative symptom control </p> </li> </ul> </p> <p><b>or</b> </p> <p> <ul id="CD015061-list-0011"> <li> <p>if it was a random sample with respect to the treatment and important prognostic factors.</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reporting bias</b> (poorly defined study group)<br/>  </p> <p>The study group was considered as well defined,</p> <p> <ul id="CD015061-list-0012"> <li> <p>if the study population is well described (e.g. severity of disease, age, risk factors)</p> </li> </ul> </p> <p><b>and</b> </p> <p> <ul id="CD015061-list-0013"> <li> <p>the intervention is well described (e.g. number of doses, volume).</p> </li> </ul> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Follow‐up</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Attrition bias</b> (incomplete outcome assessment/follow‐up ) </p> <p>The outcome assessment and follow‐up was considered as complete,</p> <p> <ul id="CD015061-list-0014"> <li> <p>if the outcome was assessed for &gt; 90% of the study group of interest (++)</p> </li> </ul> </p> <p><b>or</b> </p> <p> <ul id="CD015061-list-0015"> <li> <p>if the outcome was assessed for 60% to 90% of the study group of interest (+).</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reporting bias</b> (poorly defined follow‐up) </p> <p>The follow‐up was considered as well defined,</p> <p> <ul id="CD015061-list-0016"> <li> <p>if the length of follow‐up was mentioned.</p> </li> </ul> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Detection bias</b> (outcome assessors unblinded to investigated determinant) </p> <p>The detection bias was considered as low,</p> <p> <ul id="CD015061-list-0017"> <li> <p>if the outcome assessors were blinded to the investigated determinant.</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reporting bias</b> (poorly defined outcome) </p> <p>The outcome definition was considered as well defined,</p> <p> <ul id="CD015061-list-0018"> <li> <p>if the outcome definition was objective and precise, and the method of detection was provided. </p> </li> </ul> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk estimation</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Confounding</b> (important prognostic factors or follow‐up not adequately taken into account) </p> <p>Risk of confounding was considered as low,</p> <p> <ul id="CD015061-list-0019"> <li> <p>if important prognostic factors (i.e. age, co‐treatment, comorbidities) or follow‐up were adequately taken into account. </p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Analyses</b> (poorly defined risk estimates) </p> <p>The risk estimates were considered as well defined,</p> <p> <ul id="CD015061-list-0020"> <li> <p>if a risk ratio, odds ratio, attributable risk, linear or logistic regression model, mean difference, or Chi<sup>2</sup> was calculated. </p> </li> </ul> </p> </td> </tr> </tbody> </table> </div> <p>We assessed the following risk of bias domains.</p> <section id="CD015061-sec-0035"> <h5 class="title">Internal validity</h5> <p> <ul id="CD015061-list-0021"> <li> <p>Unrepresentative study group (selection bias)</p> </li> <li> <p>Incomplete outcome assessment/follow‐up (attrition bias)</p> </li> <li> <p>Outcome assessors unblinded to investigated determinants (detection bias)</p> </li> <li> <p>Important prognostic factors or follow‐up not taken adequately into account (confounding)</p> </li> </ul> </p> </section> <section id="CD015061-sec-0036"> <h5 class="title">External validity</h5> <p> <ul id="CD015061-list-0022"> <li> <p>Poorly defined study group (reporting bias)</p> </li> <li> <p>Poorly defined follow‐up (reporting bias)</p> </li> <li> <p>Poorly defined outcome (reporting bias)</p> </li> <li> <p>Poorly defined risk estimates (analyses)</p> </li> </ul> </p> <p>For every criterion, we made a judgement using one of three response options:</p> <p> <ul id="CD015061-list-0023"> <li> <p>high risk of bias;</p> </li> <li> <p>low risk of bias;</p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> <p>We used the highest rating to inform our overall risk of bias judgement per study outcome. </p> </section> </section> <section id="CD015061-sec-0037"> <h4 class="title">Measures of treatment effect</h4> <p>How we planned to measure the treatment effects of RCTs and NRSIs is discussed in <a href="./appendices#CD015061-sec-0096">Appendix 1</a>. </p> <p>For uncontrolled studies, we did not carry out an analysis using quantitative data from indirect controls, as we are aware of the difficulties of indirect comparisons of participant groups with varying baseline characteristics, especially in the absence of individual patient data. We did not meta‐analyze the data, but provided information from individual studies per outcome within tables. </p> </section> <section id="CD015061-sec-0038"> <h4 class="title">Unit of analysis issues</h4> <p>We collated multiple reports of one study so that each study, rather than each report, was the unit of analysis. We did not combine any data from different study designs.  </p> <p>How we planned to resolve unit of analysis issues occurring in RCTs is discussed in <a href="./appendices#CD015061-sec-0096">Appendix 1</a>.  </p> </section> <section id="CD015061-sec-0039"> <h4 class="title">Dealing with missing data</h4> <p>A number of potential sources of missing data are suggested in Chapter 6 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>, which we took into account: at study level, at outcome level, and at summary data level (<a href="./references#CD015061-bbs2-0052" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>). In the first instance, it is of the utmost importance to differentiate between data 'missing at random' and 'not missing at random.' </p> <p>We requested missing data from the study authors. The authors of two studies provided us with missing data on interventions used and outcome assessment (<a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]">Alderman 2020</a>; <a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a>). Additionally, we requested information on the exact numbers of participants in <a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a>, as there was an overlap between the two cohorts reported on in the study.  </p> </section> <section id="CD015061-sec-0040"> <h4 class="title">Assessment of heterogeneity</h4> <p>As we identified uncontrolled studies only, meta‐analysis was not appropriate. Instead, we described and presented results per study in tables, and discussed potential heterogeneity based on the methodological and clinical components of each included study. </p> <p>How we planned to assess heterogeneity in meta‐analysis is discussed in <a href="./appendices#CD015061-sec-0096">Appendix 1</a>. </p> </section> <section id="CD015061-sec-0041"> <h4 class="title">Assessment of reporting biases</h4> <p>As mentioned above, we searched trial registries to identify completed studies not published elsewhere, in order to minimize or determine whether there was publication bias. </p> <p>How we plan to assess publication bias in future versions of this review is discussed in <a href="./appendices#CD015061-sec-0116">Appendix 6</a>.  </p> </section> <section id="CD015061-sec-0042"> <h4 class="title">Data synthesis</h4> <p>We planned that if the clinical and methodological characteristics of individual studies were sufficiently homogeneous, we would pool data in meta‐analysis. We planned to perform analyses according to the recommendations in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD015061-bbs2-0045" title="DeeksJJ , HigginsJP , AltmanDG . Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Deeks 2021</a>). We would not conduct meta‐analyses that involved both RCTs and NRSIs. We planned to conduct separate meta‐analyses for each comparison. How we planned to synthesize data from RCTs and NRSIs is discussed in <a href="./appendices#CD015061-sec-0096">Appendix 1</a>. </p> <p>Meta‐analysis was not possible, therefore we synthesized study data without meta‐analysis, using the Synthesis Without Meta‐analysis (SWiM), <a href="./references#CD015061-bbs2-0041" title="CampbellM , McKenzieJE , SowdenA , KatikireddiSV , BrennanSE , EllisS , et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ2020;368(l6890):1-6. [DOI: 10.1136/bmj.l6890]">Campbell 2020</a>, guideline and Chapter 24 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>, <a href="./references#CD015061-bbs2-0078" title="ReevesBC , DeeksJJ , HigginsJPT , SheaB , TugwellP , WellsGA . Chapter 24: Including non‐randomized studies on intervention effects. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Reeves 2021</a>, to inform our approach. </p> <p>We presented outcome data individually per study within tables. For each table, we grouped studies per outcome and collated information on key study characteristics. We included information on study size, treated symptoms, and interventions for each included study. Furthermore, we visualized observed effects for each outcome and per study using histograms to portray the reported effects, so that outcome frequencies (e.g. for symptom relief) can be visually displayed and easily grasped by readers. We also noted risk of bias by color‐coding and signs to guide the reader's interpretation of our synthesis. </p> </section> <section id="CD015061-sec-0043"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Lack of adequate data precluded subgroup analysis. </p> <p>How we plan to conduct subgroup analysis in future versions of this review is discussed in <a href="./appendices#CD015061-sec-0116">Appendix 6</a>. </p> </section> <section id="CD015061-sec-0044"> <h4 class="title">Sensitivity analysis</h4> <p>Lack of adequate data precluded sensitivity analysis. </p> <p>How we plan to conduct sensitivity analysis in future versions of this review is discussed in <a href="./appendices#CD015061-sec-0116">Appendix 6</a>. </p> </section> <section id="CD015061-sec-0045"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created one summary of findings table and evaluated the certainty of the evidence using the GRADE approach. </p> <section id="CD015061-sec-0046"> <h5 class="title">Summary of findings</h5> <p>We used the MAGICapp software to create a summary of findings tables (<a href="./references#CD015061-bbs2-0063" title="MAGIC Evidence Ecosystem FoundationMAGICapp: A digital authoring and publication platform for the evidence ecosystem. MAGIC Evidence Ecosystem Foundation, 2020. Available at app.magicapp.org/.">MAGICapp 2020</a>). </p> <p>According to Chapter 14 of the updated <i>Cochrane Handbook for Systematic Reviews of Interventions</i>, the “most critical and/or important health outcomes, both desirable and undesirable, limited to seven or fewer outcomes” should be included in the summary of findings table(s) (<a href="./references#CD015061-bbs2-0082" title="SchünemannHJ , HigginsJPT , VistGE , GlasziouP , AklEA , SkoetzN , et al. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Schünemann 2021</a>). We prioritized outcomes most relevant for individuals with terminal illness, as follows. </p> <p> <ul id="CD015061-list-0024"> <li> <p>Symptom relief.</p> </li> <li> <p>Quality of life, including fatigue and neurological functions, assessed with standardized scales (e.g. McGill Quality of Life Questionnaire). </p> </li> <li> <p>Symptom burden (e.g. distress thermometer, IPOS).</p> </li> <li> <p>Satisfaction of patients.</p> </li> <li> <p>Satisfaction of caregivers and relatives.</p> </li> <li> <p>Serious adverse events, defined as number of participants with event.</p> </li> <li> <p>Grade 3 to 4 adverse events, defined as number of participants with event.</p> </li> </ul> </p> </section> <section id="CD015061-sec-0047"> <h5 class="title">Assessment of the certainty in the evidence</h5> <p>We used the GRADE approach to assess the certainty of the evidence for the outcomes listed above. </p> <p>The GRADE approach uses five domains (risk of bias, consistency of effect, imprecision, indirectness. and publication bias) to assess the certainty of the body of evidence for each prioritized outcome. According to GRADE guidance 18 (<a href="./references#CD015061-bbs2-0081" title="SchünemannHJ , CuelloC , AklEA , MustafaRA , MeerpohlJJ , ThayerK , et al. GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence. Journal of Clinical Epidemiology2019;111:105-14. [DOI: 10.1016/j.jclinepi.2018.01.012]">Schünemann 2019</a>), the initial rating for randomized trials and NRSIs (the latter rated with ROBINS‐I) is high certainty. As reported in the GRADE guidance 3, uncontrolled studies start from low‐certainty evidence (<a href="./references#CD015061-bbs2-0034" title="BalshemH , HelfandM , SchünemannHJ , OxmanAD , KunzR , BrozekJ , et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology2011;64(4):401-6. [DOI: 10.1016/j.jclinepi.2010.07.015]">Balshem 2011</a>).  </p> <p>The certainty of the evidence can be downgraded for the following reasons:</p> <p> <ul id="CD015061-list-0025"> <li> <p>serious (−1) or very serious (−2) study limitations; or moderate (−1), serious (−2), or critical (−3) study limitations for NRSIs; </p> </li> <li> <p>serious (−1) or very serious (−2) inconsistency;</p> </li> <li> <p>serious (−1) or very serious (−2) indirectness;</p> </li> <li> <p>serious (−1) or very serious (−2) imprecise or sparse data;</p> </li> <li> <p>serious (−1) or very serious (−2) publication bias.</p> </li> </ul> </p> <p>The certainty of the evidence can be upgraded for uncontrolled studies for:</p> <p> <ul id="CD015061-list-0026"> <li> <p>large effects;</p> </li> <li> <p>dose‐response; and</p> </li> <li> <p>plausible confounding.</p> </li> </ul> </p> <p>The GRADE system uses the following criteria for assigning grades of evidence.</p> <p> <ul id="CD015061-list-0027"> <li> <p>High: we are very confident that the true effect lies close to that of the estimate of the effect. </p> </li> <li> <p>Moderate: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different. </p> </li> <li> <p>Low: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. </p> </li> <li> <p>Very low: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </li> </ul> </p> <p>We followed the current GRADE guidance for these assessments in its entirety as recommended in Chapter 14 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD015061-bbs2-0082" title="SchünemannHJ , HigginsJPT , VistGE , GlasziouP , AklEA , SkoetzN , et al. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Schünemann 2021</a>). We used our overall risk of bias judgements to inform decisions on downgrading for study limitations. We phrased the findings and certainty of the evidence as suggested in the informative statement guidance of the GRADE guidance (<a href="./references#CD015061-bbs2-0080" title="SantessoN , GlentonC , DahmP , GarnerP , AklEA , AlperB , et al. GRADE guidelines 26: Informative statements to communicate the findings of systematic reviews of interventions. Journal of Clinical Epidemiology2020;1(119):126-35. [DOI: 10.1016/j.jclinepi.2019.10.014]">Santesso 2020</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD015061-sec-0048" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD015061-sec-0048"></div> <section id="CD015061-sec-0049"> <h3 class="title">Description of studies</h3> <section id="CD015061-sec-0050"> <h4 class="title">Results of the search</h4> <p>We identified 2554 potentially relevant references (2552 from database searching and 2 from other sources). After removal of duplicates, we screened 2499 references based on their titles and abstracts, excluding 2465 references as irrelevant because they did not meet the prespecified inclusion criteria. We screened the full texts of the remaining 34 references, or, if these were not available, abstract publications or trial registry entries. We identified 9 eligible studies, four of which were assessed as awaiting classification as (complete) results had not yet been published (<a href="./references#CD015061-bbs2-0028" title="ChiCTR2000029994. Liu-Zi-Jue qigong and acupressure therapy for pulmonary function and quality of life in patient with severe novel coronavirus pneumonia (COVID-19): A randomized controlled trial. Chinese Clinical Trial Registry2020. [CHICTR: 2000029994] [URL: https://www.chictr.org.cn/showprojen.aspx?proj=49309]ZhangS , ZhuQ , ZhanC , ChengW , MingfangX , FangM ,  et al. Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial. Trials2020;21(1):751. [DOI: 10.1186/s13063-020-04693-5]">ChiCTR2000029994</a>; <a href="./references#CD015061-bbs2-0029" title="GroningerH , McPhersonA , VaughanE , KangIG , KelemenA . Hospital-based palliative care experiences of patients with COVID-19. Journal of Pain and Symptom Management2021;61(3):695. [ABSTRACT NUMBER: SCI947] [DOI: 10.1016/j.jpainsymman.2021.01.108]">Groninger 2021</a>; <a href="./references#CD015061-bbs2-0030" title="KellyL , O’SheaN , AzharM , BeattyS , BrennockJ , MannionE , et al. Symptomatology at the end of life with COVID-19. Abstracts of the 16th International E-Congress of the European Geriatric Medicine Society; 2020 Oct 7-9 2020 Apr 28 [Epub ahead of print]. [ABSTRACT NUMBER: 23] [DOI: 10.1007/s41999-020-00428-6]">Kelly 2020</a>; <a href="./references#CD015061-bbs2-0031" title="OkuwogaO , PictonS , SaberS ,  O’SullivanC . Managing delirium in patients with COVID-19—lessons to learn. Abstracts of the 16th International E-Congress of the European Geriatric Medicine Society; 2020 Oct 7-9 2020 Apr 28 [Epub ahead of print]. [ABSTRACT NUMBER: 281] [DOI: 10.1007/s41999-020-00428-6]">Okuwoga 2020</a>), and one study as ongoing as participants were still being recruited (<a href="./references#CD015061-bbs2-0032" title="NCT04522037. Measurement of the efficacy of morphine in the early management of dyspnea in COVID-19 positive patients (CODYS). clinicaltrials.gov/ct2/show/NCT04522037 (first received 21 August 2020). ">NCT04522037</a>).  </p> <p>The process and results of study selection are documented in the PRISMA flow diagram (<a href="#CD015061-fig-0001">Figure 1</a>). </p> </section> <section id="CD015061-sec-0051"> <h4 class="title">Included studies</h4> <section id="CD015061-sec-0052"> <h5 class="title">Design and settings </h5> <p>An overview of the included studies and their characteristics is provided in <a href="#CD015061-tbl-0003">Table 2</a>.   </p> <div class="table" id="CD015061-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overview of included studies </span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b> </b> </p> <p><b> </b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]"><b>Alderman 2020</b> </a> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD015061-bbs2-0002" title="HetheringtonL , JohnstonB , KotronoulasG , FinlayF , KeeleyP , McKeownA . COVID-19 and hospital palliative care—a service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist hospital palliative care. Palliative Medicine2020;34(9):1256-62. [DOI: 10.1177/0269216320949786]"><b>Hetherington 2020</b> </a> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD015061-bbs2-0003" title="LovellN , MaddocksM , EtkindSN , TaylorK , CareyI , VoraV , et al. Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care. Journal of Pain and Symptom Management2020;60(1):e77-81. [DOI: 10.1016/j.jpainsymman.2020.04.015]"><b>Lovell 2020</b> </a> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]"><b>Strang 2021</b> </a> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>Study characteristics</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Setting</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015061-list-0028"> <li> <p>Hospital</p> </li> <li> <p>United Kingdom</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015061-list-0029"> <li> <p>Hospital</p> </li> <li> <p>United Kingdom</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015061-list-0030"> <li> <p>Hospital</p> </li> <li> <p>United Kingdom</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015061-list-0031"> <li> <p>Hospitals and nursing homes</p> </li> <li> <p>Sweden</p> </li> </ul> </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Design</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort study</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Protocol</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None published.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None published.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None published.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None published.</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Number of participants</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>186</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unknown*</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Symptoms treated</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Shortness of breath, delirium, audible upper airway secretions, cough, pain, nausea</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort 1: breathlessness,     anxiety, delirium, audible upper airway secretions, pain  </p> <p>Cohort 2: breathlessness, anxiety, delirium, respiratory secretions</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcome assessed </b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptom relief (assessed by clinicians)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cinical impression of efficacy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical impression of effectiveness </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptom relief (assessed by clinicians)</p> </td> </tr> <tr> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b> </b> </p> </th> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>Participant characteristics</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Age of participants </b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median age 82 (IQR 53 to 98) years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median age 76 (IQR 71 to 84) years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median age 82 (IQR 72 to 89) years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>First cohort: mean age 84.7 (range 47 to 104)</p> <p>Second cohort: </p> <p> <ul id="CD015061-list-0032"> <li> <p>Nursing homes: 86.7 (range 57 to 107)</p> </li> <li> <p>Hospitals: 83.3 (range 30 to 107)</p> </li> </ul> </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gender (male (n (%)))</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34 (55.5%)    </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98 (52.6%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64 (45.5%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort 1: 201 (52%) </p> <p>Cohort 2: </p> <p> <ul id="CD015061-list-0033"> <li> <p>Nursing homes: 1084 (57%)</p> </li> <li> <p>Hospitals: 74 (42%)</p> </li> </ul> </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comorbidities (%)</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dementia (13%), neurological disease (8%), cardiovascular disease (42.5%), hypertension (36%), respiratory disease (23%), renal disease (18%), diabetes mellitus (19.5%), cancer (24.5%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertension (31.2%), diabetes mellitus (28%), chronic obstructive pulmonary disease (26.9%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertension (53%), diabetes (35.6%), dementia (30.6%), <br/>advanced/metastatic cancer (24.7%), chronic pulmonary disease (21.7%), renal failure (20.7%), congestive heart failure (17.8%), stroke/neurological disorder (11.8%), peripheral vascular disorder (0.04%), liver disease (0.02%)<br/>  </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None reported. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: IQR: interquartile range</p> <p>*We do not know the exact number of participants since the cohorts reported on partially overlap. The first cohort included 390 participants, and the second cohort 2105 participants. It is unclear how big the overlap is between patients who died in hospitals in the first cohort (137) and nursing home residents who died in hospitals in the second cohort.  </p> </div> </div> <p>We included four uncontrolled retrospective cohort studies (five references). Three studies originated from the United Kingdom (<a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]">Alderman 2020</a>; <a href="./references#CD015061-bbs2-0002" title="HetheringtonL , JohnstonB , KotronoulasG , FinlayF , KeeleyP , McKeownA . COVID-19 and hospital palliative care—a service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist hospital palliative care. Palliative Medicine2020;34(9):1256-62. [DOI: 10.1177/0269216320949786]">Hetherington 2020</a>; <a href="./references#CD015061-bbs2-0003" title="LovellN , MaddocksM , EtkindSN , TaylorK , CareyI , VoraV , et al. Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care. Journal of Pain and Symptom Management2020;60(1):e77-81. [DOI: 10.1016/j.jpainsymman.2020.04.015]">Lovell 2020</a>), and one from Sweden (<a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a>). All four studies investigated symptom relief in people with COVID‐19 in hospital palliative care. One study also included participants from nursing homes (<a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a>). No study included a comparator.  </p> <p>Two references from <a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a> used the same register to form their cohorts, and study investigators confirmed a partial overlap of participants: the 253 participants who died in nursing homes reported on in the first cohort are a subset of 1903 participants who died in nursing homes included in the second cohort. It is unclear how big the overlap is between patients who died in hospitals in the first cohort (137) and nursing home residents who died in hospitals in the second cohort. However, the study authors estimate the overlap for the second group to be small. Consequently, we do not know the exact number of participants, but individual reports included 61 to 2105 participants.  </p> <p>The authors of two studies provided additional information upon request. <a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a> supplied us with information on the drugs prescribed for the study population and the size of the study population, and <a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]">Alderman 2020</a> provided additional information on symptom measurement for shortness of breath and delirium.  </p> </section> <section id="CD015061-sec-0053"> <h5 class="title">Participants</h5> <p>Participants in the studies all had diagnosed COVID‐19. The age of participants ranged from 30 to 107 years. The studies reported that participants showed symptoms of dyspnea, delirium, agitation, pain, audible upper airway secretions, respiratory secretions, nausea, fatigue, fever, and cough. No study provided information on the severity of symptoms. One study reported that the Australian‐modified Karnofsky performance status of participants was 20, meaning that patients were bedfast and required extensive nursing care (<a href="./references#CD015061-bbs2-0003" title="LovellN , MaddocksM , EtkindSN , TaylorK , CareyI , VoraV , et al. Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care. Journal of Pain and Symptom Management2020;60(1):e77-81. [DOI: 10.1016/j.jpainsymman.2020.04.015]">Lovell 2020</a>). Three studies reported comorbidities (<a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]">Alderman 2020</a>; <a href="./references#CD015061-bbs2-0002" title="HetheringtonL , JohnstonB , KotronoulasG , FinlayF , KeeleyP , McKeownA . COVID-19 and hospital palliative care—a service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist hospital palliative care. Palliative Medicine2020;34(9):1256-62. [DOI: 10.1177/0269216320949786]">Hetherington 2020</a>; <a href="./references#CD015061-bbs2-0003" title="LovellN , MaddocksM , EtkindSN , TaylorK , CareyI , VoraV , et al. Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care. Journal of Pain and Symptom Management2020;60(1):e77-81. [DOI: 10.1016/j.jpainsymman.2020.04.015]">Lovell 2020</a>). The most frequently reported comorbidities were hypertension, diabetes, COPD, respiratory diseases, dementia, and cancer. <a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a> did not investigate comorbidities. As older patients with comorbidities were included, we cannot be certain if COVID‐19 was the cause of death for participants in the included studies.  </p> </section> <section id="CD015061-sec-0054"> <h5 class="title">Interventions </h5> <p>All studies used pharmacological interventions for palliative symptom control, but the medications used differed between studies. Overall, opioids, benzodiazepines, anticholinergics, neuroleptics, or a combination were given for symptom relief. Two studies specified the dosing of the drugs (<a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]">Alderman 2020</a>; <a href="./references#CD015061-bbs2-0003" title="LovellN , MaddocksM , EtkindSN , TaylorK , CareyI , VoraV , et al. Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care. Journal of Pain and Symptom Management2020;60(1):e77-81. [DOI: 10.1016/j.jpainsymman.2020.04.015]">Lovell 2020</a>). Only one study specified which drugs were prescribed for which symptom (<a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]">Alderman 2020</a>). Three studies reported the mode of drug delivery. In <a href="./references#CD015061-bbs2-0003" title="LovellN , MaddocksM , EtkindSN , TaylorK , CareyI , VoraV , et al. Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care. Journal of Pain and Symptom Management2020;60(1):e77-81. [DOI: 10.1016/j.jpainsymman.2020.04.015]">Lovell 2020</a>, 58 participants were prescribed a continuous subcutaneous infusion. Continuous subcutaneous infusion was also mentioned as one mode of drug delivery in <a href="./references#CD015061-bbs2-0002" title="HetheringtonL , JohnstonB , KotronoulasG , FinlayF , KeeleyP , McKeownA . COVID-19 and hospital palliative care—a service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist hospital palliative care. Palliative Medicine2020;34(9):1256-62. [DOI: 10.1177/0269216320949786]">Hetherington 2020</a>. In <a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]">Alderman 2020</a> syringe pumps were utilized in 41 (67%) of participants. <a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a> did not specify the mode of drug delivery. None of the studies used non‐pharmacological interventions for palliative symptom control. None of the studies compared different interventions for palliative symptom control. </p> <p>Treated symptoms included dyspnea, delirium, anxiety, pain, audible upper airway secretions, respiratory secretions, nausea, cough, and unspecified symptoms. </p> <p>For details, see <a href="./references#CD015061-sec-0127" title="">Characteristics of included studies</a>.  </p> </section> <section id="CD015061-sec-0055"> <h5 class="title">Outcome measures </h5> <p>All studies assessed symptom relief. In <a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]">Alderman 2020</a>, symptom relief of shortness of breath was assessed by ward nurses noting whether the symptom was present every four hours. Symptom relief of delirium was assessed through modified Richmond Agitation and Sedation Scale (m‐RASS) scores every four hours. In <a href="./references#CD015061-bbs2-0003" title="LovellN , MaddocksM , EtkindSN , TaylorK , CareyI , VoraV , et al. Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care. Journal of Pain and Symptom Management2020;60(1):e77-81. [DOI: 10.1016/j.jpainsymman.2020.04.015]">Lovell 2020</a>, symptom relief was assessed via clinical impression of effectiveness based on follow‐up documentation of symptoms. Possible answers were "yes," "no," and "unclear." Judgement of clinical effectiveness was made based on medical and nursing case notes. It is unclear who made the judgement. Likewise, in <a href="./references#CD015061-bbs2-0002" title="HetheringtonL , JohnstonB , KotronoulasG , FinlayF , KeeleyP , McKeownA . COVID-19 and hospital palliative care—a service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist hospital palliative care. Palliative Medicine2020;34(9):1256-62. [DOI: 10.1177/0269216320949786]">Hetherington 2020</a> symptom relief was assessed via clinical impression of efficacy. Possible answers were "effective," "partially effective," and "not effective." The judgement of clinical efficacy was made by specialist palliative care clinicians. <a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a> used data from the Swedish Register of Palliative Care (SRPC), which is a national quality register that focuses on palliative care in the last week of life. It is built on data assessed with an anonymized end‐of‐life questionnaire (ELQ). The ELQ is answered retrospectively by medical staff as soon as possible after a patient dies. The ELQ contains 30 questions and provides information on provided care content and quality during the last week of life, demographics, the occurrence of breakthrough symptoms (regardless of intensity), and, if symptoms occur, the degree of symptom alleviation during the last week of life (<a href="./references#CD015061-bbs2-0088" title="The Swedish Register of Palliative Care (SRPC). www.palliativ.se (accessed prior to 9 August 2021).">Svenska Palliativregistret 2021</a>). Data in all studies were collected retrospectively.   </p> <p>No other predefined outcome was reported in the included studies.</p> <p>For details, <a href="./references#CD015061-sec-0127" title="">Characteristics of included studies</a>.  </p> </section> </section> <section id="CD015061-sec-0056"> <h4 class="title">Studies awaiting classification</h4> <p>We identified one RCT from a trial registry in China that might be relevant to this review (<a href="./references#CD015061-bbs2-0028" title="ChiCTR2000029994. Liu-Zi-Jue qigong and acupressure therapy for pulmonary function and quality of life in patient with severe novel coronavirus pneumonia (COVID-19): A randomized controlled trial. Chinese Clinical Trial Registry2020. [CHICTR: 2000029994] [URL: https://www.chictr.org.cn/showprojen.aspx?proj=49309]ZhangS , ZhuQ , ZhanC , ChengW , MingfangX , FangM ,  et al. Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial. Trials2020;21(1):751. [DOI: 10.1186/s13063-020-04693-5]">ChiCTR2000029994</a>). We contacted the authors of the study to request missing information, but received no reply. In addition, we identified three relevant conference abstracts, but data for these studies had not yet been published (<a href="./references#CD015061-bbs2-0029" title="GroningerH , McPhersonA , VaughanE , KangIG , KelemenA . Hospital-based palliative care experiences of patients with COVID-19. Journal of Pain and Symptom Management2021;61(3):695. [ABSTRACT NUMBER: SCI947] [DOI: 10.1016/j.jpainsymman.2021.01.108]">Groninger 2021</a>; <a href="./references#CD015061-bbs2-0030" title="KellyL , O’SheaN , AzharM , BeattyS , BrennockJ , MannionE , et al. Symptomatology at the end of life with COVID-19. Abstracts of the 16th International E-Congress of the European Geriatric Medicine Society; 2020 Oct 7-9 2020 Apr 28 [Epub ahead of print]. [ABSTRACT NUMBER: 23] [DOI: 10.1007/s41999-020-00428-6]">Kelly 2020</a>; <a href="./references#CD015061-bbs2-0031" title="OkuwogaO , PictonS , SaberS ,  O’SullivanC . Managing delirium in patients with COVID-19—lessons to learn. Abstracts of the 16th International E-Congress of the European Geriatric Medicine Society; 2020 Oct 7-9 2020 Apr 28 [Epub ahead of print]. [ABSTRACT NUMBER: 281] [DOI: 10.1007/s41999-020-00428-6]">Okuwoga 2020</a>). Data from these three studies would add a further 384 participants. Interventions investigated in these studies are Liu Zi Jue Qigong and acupressure (<a href="./references#CD015061-bbs2-0028" title="ChiCTR2000029994. Liu-Zi-Jue qigong and acupressure therapy for pulmonary function and quality of life in patient with severe novel coronavirus pneumonia (COVID-19): A randomized controlled trial. Chinese Clinical Trial Registry2020. [CHICTR: 2000029994] [URL: https://www.chictr.org.cn/showprojen.aspx?proj=49309]ZhangS , ZhuQ , ZhanC , ChengW , MingfangX , FangM ,  et al. Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial. Trials2020;21(1):751. [DOI: 10.1186/s13063-020-04693-5]">ChiCTR2000029994</a>); pharmacological interventions such as morphine to manage dyspnea (<a href="./references#CD015061-bbs2-0030" title="KellyL , O’SheaN , AzharM , BeattyS , BrennockJ , MannionE , et al. Symptomatology at the end of life with COVID-19. Abstracts of the 16th International E-Congress of the European Geriatric Medicine Society; 2020 Oct 7-9 2020 Apr 28 [Epub ahead of print]. [ABSTRACT NUMBER: 23] [DOI: 10.1007/s41999-020-00428-6]">Kelly 2020</a>); injectable medications for symptom relief of agitation and delirium (<a href="./references#CD015061-bbs2-0031" title="OkuwogaO , PictonS , SaberS ,  O’SullivanC . Managing delirium in patients with COVID-19—lessons to learn. Abstracts of the 16th International E-Congress of the European Geriatric Medicine Society; 2020 Oct 7-9 2020 Apr 28 [Epub ahead of print]. [ABSTRACT NUMBER: 281] [DOI: 10.1007/s41999-020-00428-6]">Okuwoga 2020</a>); and benzodiazepines and neuroleptics for not further classified symptoms (<a href="./references#CD015061-bbs2-0029" title="GroningerH , McPhersonA , VaughanE , KangIG , KelemenA . Hospital-based palliative care experiences of patients with COVID-19. Journal of Pain and Symptom Management2021;61(3):695. [ABSTRACT NUMBER: SCI947] [DOI: 10.1016/j.jpainsymman.2021.01.108]">Groninger 2021</a>).  </p> </section> <section id="CD015061-sec-0057"> <h4 class="title">Ongoing studies </h4> <p>We identified one ongoing study that is still recruiting participants (<a href="./references#CD015061-bbs2-0032" title="NCT04522037. Measurement of the efficacy of morphine in the early management of dyspnea in COVID-19 positive patients (CODYS). clinicaltrials.gov/ct2/show/NCT04522037 (first received 21 August 2020). ">NCT04522037</a>). This controlled study aims to investigate morphine to manage dyspnea in COVID‐19 patients. </p> </section> <section id="CD015061-sec-0058"> <h4 class="title">Excluded studies</h4> <p>We excluded 23 studies (24 references), as follows.</p> <p> <ul id="CD015061-list-0034"> <li> <p>Seven studies (eight references) evaluated the use but not the effects of palliative care (<a href="./references#CD015061-bbs2-0012" title="Haydar A, LoKB , Goyal A, Gul F, PetersonE , Bhargav R, et al. Palliative care utilization among patients with COVID-19 in an underserved population: a single-center retrospective study. Journal of Pain and Symptom Management2020;60(2):e18-21. [DOI: 10.1016/j.jpainsymman.2020.05.022]PettusK , deLimaL . Update to the fast tracked article entitled: palliative care utilization among patients with COVID-19 in an underserved population: a single-center retrospective study. Journal of Pain and Symptom Management2020;60(4):e1. [DOI: 10.1016/j.jpainsymman.2020.07.017]">Haydar 2020</a>; <a href="./references#CD015061-bbs2-0013" title="HeathL , YatesS , CareyM , MillerM . Palliative care during COVID-19: data and visits from loved ones. Journal of Hospice and Palliative Medicine2020;37(11):988-91. [DOI: 10.1177/1049909120943577]">Heath 2020</a>; <a href="./references#CD015061-bbs2-0022" title="PavluD , DeMarcoK , Sobrino-BonillaY . Field notes from the frontline of a COVID-19 outbreak: dyspnea management for hospitalized patients at end-of-life. Journal of Hospital &amp; Palliative Nursing2020;23(2):128-34. [DOI: 10.1097/NJH.0000000000000728]">Pavlu 2020</a>; <a href="./references#CD015061-bbs2-0023" title="RaoA , ZaaqoqAM , KangIG , VaughanEM , FloresJ , Avila-QuinteroVJ , et al. Palliative care for patients on extracorporeal membrane oxygenation for COVID-19 infection. American Journal of Hospice and Palliative Medicine 2021 March 9 [Epub ahead of print]. [DOI: 10.1177/10499091211001009]">Rao 2021</a>; <a href="./references#CD015061-bbs2-0025" title="RivaL , CaraceniA , VigoritaF , BertiJ , MartinelliMP , CrippaM , et al. COVID-19 emergency and palliative medicine: an intervention model. BMJ Supportive &amp; Palliative Care 2020 Nov 23 [Epub ahead of print]. [DOI: 10.1136/bmjspcare-2020-002561]">Riva 2020</a>; <a href="./references#CD015061-bbs2-0026" title="SunH , LeeJ , MeyerBJ , MyersEL , NishikawaMS , TischlerJL , et al. Characteristics and palliative care needs of COVID‐19 patients receiving comfort‐directed care. Journal of the American Geriatrics Society2020;68(8):1162-4. [DOI: 10.1111/jgs.16507]">Sun 2020</a>; <a href="./references#CD015061-bbs2-0027" title="TurnerJ , Eliot HodgsonL , LeckieT , EadeL , Ford-DunnS . A dual-center observational review of hospital-based palliative care in patients dying with COVID-19. Journal of Pain and Symptom Management2020;60(2):e75-8. [DOI: 10.1016/j.jpainsymman.2020.04.031]">Turner 2020</a>). </p> </li> <li> <p>Fifteen studies did not investigate palliative symptom control or did not further specify symptom control (<a href="./references#CD015061-bbs2-0005" title="ACTRN12620000443998p. Home rehabilitation for people with COVID-19: implementing telehealth approaches to care. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=379528&amp;isReview=true (first received 31 March 2020). ">ACTRN12620000443998p</a>; <a href="./references#CD015061-bbs2-0006" title="Allande CussóR , Navarro NavarroC , Porcel GálvezAM . Humanized care in a death for COVID-19: a case study [El cuidado humanizado en la muerte por COVID-19: a propósito de un caso]. Enfermería Clínica2021;(31):62-7. [DOI: 10.1016/j.enfcli.2020.05.018]">Allande Cussó 2020</a>; <a href="./references#CD015061-bbs2-0007" title="AnneserJ . Dying patients with COVID-19: what should hospital palliative care teams (HPCTs) be prepared for?Palliative &amp; Supportive Care2020;18(4):382-4. ">Anneser 2020</a>; <a href="./references#CD015061-bbs2-0008" title="BissonE , PresswoodE , KenyonJ , SheltonF , HallT . Against the odds: unlikely COVID-19 recovery. BMJ Supportive and Palliative Care 3 July 2020 [Epub ahead of print]. [DOI: 10.1136/bmjspcare-2020-002477]">Bisson 2020</a>; <a href="./references#CD015061-bbs2-0009" title="CookDJ , TakaokaA , HoadN , SwintonM , ClarkeFJ , RudkowskiJC , et al. Clinician perspectives on caring for dying patients during the pandemic: a mixed-methods study. Annals of Internal Medicine 2020 Dec 8 [Epub ahead of print]. [DOI: 10.7326/M20-6943]">Cook 2020</a>; <a href="./references#CD015061-bbs2-0010" title="DelisleS , HellerFE , BlindermanCD . Prolonged critical illness and demoralization: curative factors in hospice care in the age of COVID-19. Journal of Hospice &amp; Palliative Nursing2020;22(6):428-31. [DOI: 10.1097/NJH.0000000000000689]">Delisle 2020</a>; <a href="./references#CD015061-bbs2-0011" title="GalazziA , BrioniM , MistralettiG , RoselliP , AbbruzzeseC . The last farewell by video call. Minerva Anestesiologica2020;86(11):1254-5. [DOI: 10.23736/S0375-9393.20.14906-X]">Galazzi 2020</a>; <a href="./references#CD015061-bbs2-0014" title="ISRCTN16561225. CovPall: Improving palliative care for people affected by the COVID-19 pandemic by sharing learning—the national and international response. www.isrctn.com/ISRCTN16561225 (first received 5 May 2020). [DOI: 10.1186/ISRCTN16561225]">ISRCTN16561225</a>; <a href="./references#CD015061-bbs2-0015" title="JohnstonB , BladesS . COVID-19: using ‘knitted hearts’ in end-of-life care to enable continuing bonds and memory making. International Journal of Palliative Nursing2020;26(8):391-3. ">Johnston 2020</a>; <a href="./references#CD015061-bbs2-0016" title="LeeJ , AbrukinL , FloresS , GavinN , RomneyML , BlindermanCD , et al. Early intervention of palliative care in the emergency department during the COVID-19 pandemic. JAMA Internal Medicine2020;180(9):1252-4. [DOI: 10.1001/jamainternmed.2020.2713]">Lee 2020</a>; <a href="./references#CD015061-bbs2-0017" title="LopezS , FinufKD , MarzilianoA , SinvaniL , BurnsEA . Palliative care consultation in hospitalized patients with COVID-19: a retrospective study of characteristics, outcomes, and unmet needs. Journal of Pain and Symptom Management2021;62(2):276. [DOI: 10.1016/j.jpainsymman.2020.12.015]">Lopez 2020</a>; <a href="./references#CD015061-bbs2-0018" title="MartinssonL , StrangP , BergströmJ , LundströmS . Were clinical routines for good end-of-life care maintained in hospitals and nursing homes during the first three months of the outbreak of COVID-19? A national register study. Journal of Pain and Symptom Management2021;61(1):e11-9. [DOI: 10.1016/j.jpainsymman.2020.09.043]">Martinsson 2021</a>; <a href="./references#CD015061-bbs2-0020" title="MumoliN , FlorianC , CeiM , EvangelistaI , ColomboA , RazionaleG , et al. Palliative care in a COVID-19 internal medicine ward: a preliminary report. International Journal of Infectious Disease2021;105:141-3. [DOI: 10.1016/j.ijid.2021.02.053]">Mumoli 2021</a>; <a href="./references#CD015061-bbs2-0021" title="PaiceJA , WholihanD , DahlinC , RosaWE , MazanecP , LongCO , et al. Palliative nursing: the core of COVID-19 care. Journal of Hospice &amp; Palliative Nursing2021;23(1):1-6. [DOI: 10.1097/NJH.0000000000000709]">Paice 2021</a>; <a href="./references#CD015061-bbs2-0024" title="RitcheyKC , FoyA , McArdelE , GruenewaldDA . Reinventing palliative care delivery in the era of COVID-19: how telemedicine can support end of life care. American Journal of Hospice and Palliative Medicine2020;37(11):992-7. [DOI: 10.1177/1049909120948235]">Ritchey 2020</a>). </p> </li> <li> <p>One study was an opinion piece (<a href="./references#CD015061-bbs2-0019" title="MendozaA . Palliative care during a pandemic. www.providermagazine.com/Monthly-Issue/2020/September/Pages/Palliative-Care-During-a-Pandemic.aspx. ">Mendoza 2020</a>). </p> </li> </ul> </p> </section> </section> <section id="CD015061-sec-0059"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD015061-sec-0060"> <h4 class="title">Overall judgement</h4> <p>We rated the risk of bias within and across studies overall to be high. In addition to the high risk of bias related to the non‐randomised and uncontrolled study design, we assessed the internal and external validity as outlined in the 'risk of bias assessment criteria for observational studies' tool provided by the Cochrane Childhood Cancer Group (<a href="#CD015061-tbl-0002">Table 1</a>) (<a href="./references#CD015061-bbs2-0071" title="MulderRL , BrestersD , Van den HofM , KootBG , CastellinoSM , LokeYK , et al. Hepatic late adverse effects after antineoplastic treatment for childhood cancer. Cochrane Database of Systematic Reviews2019, Issue 4. Art. No: CD008205. [DOI: 10.1002/14651858.CD008205.pub3]">Mulder 2019</a>). The full judgement per trial and category is presented in <a href="#CD015061-fig-0002">Figure 2</a>, and the support for judgement in the <a href="./references#CD015061-sec-0127" title="">Characteristics of included studies</a> table. </p> <div class="figure" id="CD015061-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Summary of risk of bias. " data-id="CD015061-fig-0002" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary of risk of bias. </p> </div> </div> </div> </section> <section id="CD015061-sec-0061"> <h4 class="title">Allocation</h4> <p>We considered all studies to be at low risk of selection bias since all studies were retrospective cohort studies that included all patients in palliative care in a certain time frame.  </p> </section> <section id="CD015061-sec-0062"> <h4 class="title">Blinding</h4> <p>All studies were unblinded to interventions and therefore at high risk of detection bias for subjective outcomes. The outcome symptom relief was assessed by physicians or hospital staff, thus all studies were at high risk of detection bias. </p> </section> <section id="CD015061-sec-0063"> <h4 class="title">Incomplete outcome data</h4> <p>We assessed attrition bias in terms of whether studies (equally) assessed outcomes for all participants. We evaluated attrition bias for the outcome symptom relief. We rated attrition bias as high for one study (<a href="./references#CD015061-bbs2-0003" title="LovellN , MaddocksM , EtkindSN , TaylorK , CareyI , VoraV , et al. Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care. Journal of Pain and Symptom Management2020;60(1):e77-81. [DOI: 10.1016/j.jpainsymman.2020.04.015]">Lovell 2020</a>), as 13 participants died before follow‐up. We rated attrition bias as low for <a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]">Alderman 2020</a>, <a href="./references#CD015061-bbs2-0002" title="HetheringtonL , JohnstonB , KotronoulasG , FinlayF , KeeleyP , McKeownA . COVID-19 and hospital palliative care—a service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist hospital palliative care. Palliative Medicine2020;34(9):1256-62. [DOI: 10.1177/0269216320949786]">Hetherington 2020</a>, and <a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a>, as the authors only measured symptom relief in participants that had died or had been discharged retrospectively. We considered outcome assessment to be complete for these three studies.  </p> </section> <section id="CD015061-sec-0064"> <h4 class="title">Selective reporting</h4> <p>We assessed reporting bias in terms of whether the study group and intervention were well defined and whether the outcomes were equally reported for all participants. </p> <p>We evaluated reporting bias for the outcome symptom relief.</p> <section id="CD015061-sec-0065"> <h5 class="title">Poorly defined study group and intervention</h5> <p>We judged the risk of reporting bias to be high for all studies. While the study population was well defined in all studies, the interventions were not well described. Only <a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]">Alderman 2020</a> specified which pharmacological treatment was used to treat which symptoms. Furthermore, only two studies listed the doses of the pharmacological interventions (<a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]">Alderman 2020</a>; <a href="./references#CD015061-bbs2-0003" title="LovellN , MaddocksM , EtkindSN , TaylorK , CareyI , VoraV , et al. Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care. Journal of Pain and Symptom Management2020;60(1):e77-81. [DOI: 10.1016/j.jpainsymman.2020.04.015]">Lovell 2020</a>). </p> </section> <section id="CD015061-sec-0066"> <h5 class="title">Poorly defined outcomes</h5> <p>We considered the risk of reporting bias to be high for three studies (<a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]">Alderman 2020</a>; <a href="./references#CD015061-bbs2-0002" title="HetheringtonL , JohnstonB , KotronoulasG , FinlayF , KeeleyP , McKeownA . COVID-19 and hospital palliative care—a service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist hospital palliative care. Palliative Medicine2020;34(9):1256-62. [DOI: 10.1177/0269216320949786]">Hetherington 2020</a>; <a href="./references#CD015061-bbs2-0003" title="LovellN , MaddocksM , EtkindSN , TaylorK , CareyI , VoraV , et al. Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care. Journal of Pain and Symptom Management2020;60(1):e77-81. [DOI: 10.1016/j.jpainsymman.2020.04.015]">Lovell 2020</a>), as symptom relief was measured subjectively by physicians and hospital staff responsible for palliative care. Symptom relief was measured on a validated scale in <a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a>, resulting in a judgement of low risk of reporting bias for this study. </p> </section> <section id="CD015061-sec-0067"> <h5 class="title">Poorly defined follow‐up</h5> <p>We considered the risk of reporting bias for follow‐up to be high for <a href="./references#CD015061-bbs2-0002" title="HetheringtonL , JohnstonB , KotronoulasG , FinlayF , KeeleyP , McKeownA . COVID-19 and hospital palliative care—a service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist hospital palliative care. Palliative Medicine2020;34(9):1256-62. [DOI: 10.1177/0269216320949786]">Hetherington 2020</a> and <a href="./references#CD015061-bbs2-0003" title="LovellN , MaddocksM , EtkindSN , TaylorK , CareyI , VoraV , et al. Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care. Journal of Pain and Symptom Management2020;60(1):e77-81. [DOI: 10.1016/j.jpainsymman.2020.04.015]">Lovell 2020</a>, as the authors did not clearly define length of follow‐up. We judged the risk of reporting bias for follow‐up to be low for <a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]">Alderman 2020</a> and <a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a>, as participants were followed up until death.  </p> </section> </section> <section id="CD015061-sec-0068"> <h4 class="title">Other potential sources of bias</h4> <section id="CD015061-sec-0069"> <h5 class="title">Confounding</h5> <p>None of the included studies adjusted for confounding factors such as age, gender, or comorbidities of participants, therefore all studies were at high risk of confounding. </p> </section> <section id="CD015061-sec-0070"> <h5 class="title">Poorly defined risk estimates</h5> <p>None of the studies performed any statistical analyses.</p> </section> </section> </section> <section id="CD015061-sec-0071"> <h3 class="title" id="CD015061-sec-0071">Effects of interventions</h3> <p>See: <a href="./full#CD015061-tbl-0001"><b>Summary of findings 1</b> Pharmacological interventions for palliative symptom control</a> </p> <section id="CD015061-sec-0072"> <h4 class="title">Pharmacological interventions for palliative symptom control</h4> <p>We identified four uncontrolled retrospective cohort studies investigating pharmacological interventions for palliative symptom control in hospitalized patients and patients in nursing homes. None of the studies included a comparator. See <a href="./full#CD015061-tbl-0001">summary of findings Table 1</a>.  </p> <section id="CD015061-sec-0073"> <h5 class="title">Primary outcome</h5> <section id="CD015061-sec-0074"> <h6 class="title">Symptom relief </h6> <p>All studies reported symptom relief. Statistical pooling of data was not possible due to heterogenous studies and participant and intervention characteristics. We summarized and visualized data per study in <a href="#CD015061-fig-0003">Figure 3</a>, <a href="#CD015061-fig-0004">Figure 4</a>, <a href="#CD015061-fig-0005">Figure 5</a>, <a href="#CD015061-fig-0006">Figure 6</a>, <a href="#CD015061-fig-0007">Figure 7</a>, <a href="#CD015061-fig-0008">Figure 8</a>, <a href="#CD015061-fig-0009">Figure 9</a>, <a href="#CD015061-fig-0010">Figure 10</a>, <a href="#CD015061-fig-0011">Figure 11</a> and below. </p> <div class="figure" id="CD015061-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Visual synthesis of Alderman 2020" data-id="CD015061-fig-0003" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-03.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Visual synthesis of Alderman 2020</p> </div> </div> </div> <div class="figure" id="CD015061-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Visual synthesis for Alderman 2020" data-id="CD015061-fig-0004" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-04.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Visual synthesis for Alderman 2020</p> </div> </div> </div> <div class="figure" id="CD015061-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Visual synthesis for Hetherington 2020" data-id="CD015061-fig-0005" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-05.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Visual synthesis for Hetherington 2020</p> </div> </div> </div> <div class="figure" id="CD015061-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Visual synthesis for Lovell 2020" data-id="CD015061-fig-0006" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-06.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Visual synthesis for Lovell 2020</p> </div> </div> </div> <div class="figure" id="CD015061-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Visual synthesis for Strang 2021a" data-id="CD015061-fig-0007" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-07.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Visual synthesis for Strang 2021a</p> </div> </div> </div> <div class="figure" id="CD015061-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Visual synthesis for Strang 2021a" data-id="CD015061-fig-0008" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-08.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Visual synthesis for Strang 2021a</p> </div> </div> </div> <div class="figure" id="CD015061-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Visual synthesis for Strang 2021a" data-id="CD015061-fig-0009" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-09.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Visual synthesis for Strang 2021a</p> </div> </div> </div> <div class="figure" id="CD015061-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="Visual synthesis for Strang 2021b" data-id="CD015061-fig-0010" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-10.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Visual synthesis for Strang 2021b</p> </div> </div> </div> <div class="figure" id="CD015061-fig-0011"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 11</div> </div> <hr class="top"/><img alt="Visual synthesis for Strang 2021b" data-id="CD015061-fig-0011" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-11.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Visual synthesis for Strang 2021b</p> </div> </div> </div> <p><a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]">Alderman 2020</a> reported on 61 participants. Symptom relief for breathlessness was assessed by ward nurses during four‐hourly reviews, who indicated through a "yes/no" answer whether the symptom was present or not. A continuous subcutaneous infusion of morphine was applied to relieve shortness of breath. After four hours, the symptom was not present in 10 out of 16 participants. Relief for delirium was assessed by m‐RASS scores reported by nursing staff every four hours. Fourteen of 14 participants who were started on a continuous subcutaneous infusion either of haloperidol (first‐line treatment; n = 7), levomepromazine (second‐line treatment; n = 14), or levomepromazine and midazolam (third‐line treatment; n = 1) at the initial assessment had relief of agitation/delirium within four hours. Seven of these participants had no further episodes of agitation. In the last 72 hours of life, only one participant of the cohort had an m‐RASS score as high as three (very agitated), and no participant had an m‐RASS score of four (combative). One of 11 participants with persistent audible upper airway secretions did not respond to glycopyrronium, and two participants with nausea, one of whom was treated with haloperidol, did not have nausea at final assessment. One of four participants had pain at final assessment. For a visual synthesis, please see <a href="#CD015061-fig-0003">Figure 3</a> and <a href="#CD015061-fig-0004">Figure 4</a>.  </p> <p><a href="./references#CD015061-bbs2-0002" title="HetheringtonL , JohnstonB , KotronoulasG , FinlayF , KeeleyP , McKeownA . COVID-19 and hospital palliative care—a service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist hospital palliative care. Palliative Medicine2020;34(9):1256-62. [DOI: 10.1177/0269216320949786]">Hetherington 2020</a> reported on 186 participants. Symptom relief was not measured on a standardized scale, but assessed by a palliative care specialist in 126 participants to be "effective," "partially effective," or "not effective." The study authors described pharmacological treatment for symptom control as "effective" in 99 of 126 (79%) participants; "partially effective" in 24 of 126 (19%) participants; and "not effective" in 3 of 126 (2%) participants. No further information was provided with regard to the definition or assessment of effectiveness. For a visual synthesis, please see <a href="#CD015061-fig-0005">Figure 5</a>. </p> <p><a href="./references#CD015061-bbs2-0003" title="LovellN , MaddocksM , EtkindSN , TaylorK , CareyI , VoraV , et al. Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care. Journal of Pain and Symptom Management2020;60(1):e77-81. [DOI: 10.1016/j.jpainsymman.2020.04.015]">Lovell 2020</a> reported on 101 participants. The clinical impression of effectiveness was determined based on documentation at follow‐up. Possible answers for the clinical impression of effectiveness were "yes," "no," and "unclear." The study authors described pharmacological treatment for symptom control as effective for 40 of 58 (69%) participants and not effective for 5 of 58 (9%) participants. Treatment effectiveness was rated as unclear for 13 (22%) participants who died before follow‐up. Effectiveness was not measured on a standardized scale. For a visual synthesis, please see <a href="#CD015061-fig-0006">Figure 6</a>.  </p> <p><a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a> reported on two cohorts extracted from the same registry. We do not know how many participants were reported on twice, and the study investigators were unable to provide this precise information. The first cohort encompassed 390 participants (data retrieved April 2020). Clinical impression of the effectiveness of symptom relief was rated on the ELQ for each participant by the nurse or physician responsible for palliative care. Answer alternatives were "completely relieved," "partly relieved," and "not relieved at all." Complete relief was reached in 53 of 173 (31%) participants with breathlessness, 131 of 197 (66%) participants with anxiety, 13 of 77 (17%) participants with delirium, 72 of 178 (40%) participants with death rattles, and 162 of 210 (77%) participants with pain. Partial relief was reached in 109 of 173 (63%) participants with breathlessness, 63 of 197 (32%) participants with anxiety, 47 of 77 (61%) participants with delirium, 99 of 178 (56%) of participants with death rattles, and 47 of 210 (22%) participants with pain. No relief was reached in 11 of 173 (6%) participants with breathlessness, 3 of 197 (2%) participants with anxiety, 17 of 47 (36%) participants with delirium, 7 of 178 (4%) participants with death rattles, and 1 of 210 (0.5%) participants with pain.  </p> <p>Additionally, <a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a> reported symptom relief separately for the subgroups of nursing home residents who died in nursing homes and those who died in the hospital in this cohort. For 253 participants who died in nursing homes, complete relief was reached in 35 of 84 (42%) participants with breathlessness, 96 of 131 (%) participants with anxiety, 7 of 38 (18%) participants with delirium, 54 of 118 (46%) participants with death rattles, and 122 of 147 (83%) participants with pain. Partial relief in this subgroup was reached in 45 of 84 (54%) participants with breathlessness, 33 of 131 (25%) participants with anxiety, 21 of 38 (55%) participants with delirium, 61 of 118 (52%) participants with death rattles, and 25 of 147 (17%) participants with pain. No relief was reached in 4 of 84 (5%) participants with breathlessness, 2 of 131 (2%) participants with anxiety, 10 of 38 (26%) participants with delirium, 3 of 118 participants (3%) with death rattles, and no participants with pain. For 137 participants who died in the hospital, complete relief was reached in 18 of 89 (20%) participants with breathlessness, 35 of 66 (53%) participants with anxiety, 6 of 39 (15%) participants with delirium, 18 of 60 (30%) participants with death rattles, and 40 of 63 (63%) participants with pain. Partial relief in this subgroup was reached in 64 of 89 (72%) participants with breathlessness, 30 of 66 (45%) participants with anxiety, 26 of 39 (67%) participants with delirium, 38 of 60 (63%) participants with death rattles, and 22 of 63 (35%) participants with pain. No relief was reached in 7 of 89 (8%) participants with breathlessness, 1 of 66 (2%) participants with anxiety, 7 of 39 (18%) participants with delirium, 4 of 60 (7%) participants with death rattles, and 1 of 63 (2%) participants with pain. For a visual synthesis, please see <a href="#CD015061-fig-0007">Figure 7</a>, <a href="#CD015061-fig-0008">Figure 8</a> and <a href="#CD015061-fig-0009">Figure 9</a>.  </p> <p>The second cohort reported on by <a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a> was retrieved in August 2020. The number of participants assessed was 2105. Complete relief was reached in 291 of 665 (44%) participants with breathlessness, 832 of 1117 (74%) participants with anxiety, 154 of 486 (32%) participants with delirium, and 559 of 1053 (53%) participants with respiratory secretions. Partial relief was reached in 352 of 665 (53%) participants with breathlessness, 277 of 1117 (25%) participants with anxiety, 230 of 486 (47%) participants with delirium, and 469 of 1053 (45%) participants with respiratory secretions. No relief was reached in 22 of 665 (3%) participants with breathlessness, 8 of 1117 (0.7%) participants with anxiety, 102 of 486 (21%) participants with delirium, and 25 of 1053 (2%) participants with respiratory secretions. </p> <p>Additionally, <a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a> reported symptom relief separately for the subgroups of nursing home residents who died in nursing homes and those who died in the hospital in this cohort. In 1903 nursing home patients, complete relief was reached in 261 of 556 (47%) participants with breathlessness, 769 of 1015 (76%) participants with anxiety, 148 of 423 (35%) participants with delirium, and 530 of 956 (55%) participants with respiratory secretions. Partial relief was reached in 280 of 556 (50%) participants with breathlessness, 238 of 1015 (23%) participants with anxiety, 198 of 423 (47%) participants with delirium, and 408 of 956 (43%) participants with respiratory secretions. No relief was reached in 15 of 556 (3%) participants with breathlessness, 8 of 1015 (0.8%) participants with anxiety, 77 of 423 (18%) participants with delirium, and 18 of 956 (2%) participants with respiratory secretions. For 202 nursing home patients who died in the hospital, complete relief was reached in 30 of 109 (28%) participants with breathlessness, 63 of 102 (62%) participants with anxiety, 6 of 63 (10%) participants with delirium, and 29 of 97 (30%) participants with respiratory secretions. Partial relief was reached in 72 of 109 (66%) participants with breathlessness, 39 of 102 (38%) participants with anxiety, 32 of 63 (51%) participants with delirium, and 61 of 97 (63%) participants with respiratory secretions. No relief was reached in 7 of 109 (6%) participants with breathlessness, 0 of 102 (0%) participants with anxiety, 25 of 63 (40%) participants with delirium, and 7 of 97 (7%) participants with respiratory secretions. For a visual synthesis, please see <a href="#CD015061-fig-0010">Figure 10</a> and <a href="#CD015061-fig-0011">Figure 11</a>.  </p> <p>In summary, all studies rated a majority of interventions as effective to relieve dyspnea, delirium, anxiety, pain, audible upper airway secretions, respiratory secretions, nausea, cough, and unspecified symptoms. We are very uncertain about the effect of opioids, neuroleptics, anticholinergics, and benzodiazepines on symptom relief in individuals with COVID‐19. The initial rating of the certainty of the evidence was low due to the non‐randomized study design. Additionally, our main reason for downgrading the certainty of the evidence was high risk of bias due to confounding and unblinded outcome assessors. </p> </section> </section> <section id="CD015061-sec-0075"> <h5 class="title">Secondary outcomes</h5> <p>We planned to assess the following secondary outcomes.</p> <p> <ul id="CD015061-list-0035"> <li> <p>Quality of life, including fatigue and neurological functions, assessed with standardized scales (e.g. McGill Quality of Life Questionnaire). </p> </li> <li> <p>Symptom burden (e.g. distress thermometer, IPOS).</p> </li> <li> <p>Satisfaction of patients.</p> </li> <li> <p>Satisfaction of caregivers and relatives.</p> </li> <li> <p>Serious adverse events, defined as number of participants with event.</p> </li> <li> <p>Grade 3 to 4 adverse events, defined as number of participants with event.</p> </li> </ul> </p> <p>However, none of the included studies provided data for these outcomes, or any other information to describe the efficacy and safety of used interventions. </p> </section> </section> <section id="CD015061-sec-0076"> <h4 class="title">Non‐pharmacological interventions for palliative symptom control  </h4> <p>None of the included studies used non‐pharmacological interventions for palliative symptom control. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD015061-sec-0077" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD015061-sec-0077"></div> <section id="CD015061-sec-0078"> <h3 class="title" id="CD015061-sec-0078">Summary of main results</h3> <p>The aim of this systematic review was to synthesize all available evidence on pharmacological and non‐pharmacological treatment options for palliative symptom control in people with COVID‐19. We identified four retrospective cohort studies from the United Kingdom and Sweden. None of the studies included a comparator. </p> <p>The identified studies used different pharmacological treatments for symptom control; none of the studies used non‐pharmacological interventions. The treatments were opioids, neuroleptics, anticholinergics, and benzodiazepines. Pharmacological interventions were used to control dyspnea, delirium, anxiety, pain, audible upper airway secretions, respiratory secretions, nausea, cough, and unspecified symptoms. The results and the certainty of the evidence for the main outcomes are summarized in the summary of findings table (<a href="./full#CD015061-tbl-0001">summary of findings Table 1</a>), the evidence synthesis table (Figure 3), and below for the outcome symptom relief. </p> <section id="CD015061-sec-0079"> <h4 class="title">Effects of interventions</h4> <section id="CD015061-sec-0080"> <h5 class="title">Pharmacological interventions for palliative symptom control</h5> <section id="CD015061-sec-0081"> <h6 class="title">Primary outcome: symptom relief</h6> <p>We identified four retrospective cohort studies (five references) reporting this outcome. Two references used the same register to form their cohorts, and study investigators confirmed a partial overlap of participants. We therefore do not know the exact number of participants, but individual reports included 61 to 2105 participants. For all symptoms (dyspnea, delirium, anxiety, pain, audible upper airway secretions, respiratory secretions, nausea, cough, and unspecified symptoms), a majority of interventions were rated as completely or partially effective by outcome assessors. Interventions were opioids, neuroleptics, anticholinergics, and benzodiazepines.  </p> <p>We are very uncertain about the effect of pharmacological interventions on symptom relief (very low‐certainty evidence). Based on the uncontrolled study design, we do not know whether one treatment worked better than other treatments for individuals with COVID‐19. The initial rating of the certainty of the evidence was low due to the non‐randomized study design. Additionally, our main reason for downgrading the certainty of the evidence was high risk of bias due to confounding and unblinded outcome assessors. </p> </section> <section id="CD015061-sec-0082"> <h6 class="title">Secondary outcomes</h6> <p>We planned to include the following outcomes: quality of life; symptom burden; satisfaction of patients, caregivers, and relatives; serious adverse events; and grade 3 to 4 adverse events. </p> <p>We did not find any data on these outcomes, or any other information on the efficacy and safety of used interventions. </p> </section> </section> <section id="CD015061-sec-0083"> <h5 class="title">Non‐pharmacological interventions for palliative symptom control</h5> <p>None of the included studies used non‐pharmacological interventions for palliative symptom control. </p> </section> </section> </section> <section id="CD015061-sec-0084"> <h3 class="title" id="CD015061-sec-0084">Overall completeness and applicability of evidence</h3> <p>The included studies reported data for one of our predefined outcomes. We found very low‐certainty evidence about the effect of multimodal pharmacological interventions (opioids, neuroleptics, anticholinergics, and benzodiazepines) on relieving dyspnea, delirium, anxiety, pain, audible upper airway secretions, respiratory secretions, nausea, cough, and unspecified symptoms, at the end of life. None of the studies provided information on quality of life; symptom burden; satisfaction of patients, caregivers, and relatives; or adverse events and serious adverse events. </p> <p>The identified evidence has a limited informative value with regard to our review question because the described pharmacological interventions could not be matched to the reported outcomes, and there was no control for the interventions. Furthermore, outcomes for symptom relief were assessed by clinical staff and not by the patients themselves. Although it is not always possible for palliative patients to report their symptoms themselves, self‐reported outcome measures remain the gold standard and should be used whenever possible (<a href="./references#CD015061-bbs2-0033" title="AntunesB , HardingR , HigginsonIJ . Implementing patient-reported outcome measures in palliative care clinical practice: a systematic review of facilitators and barriers. Palliative Medicine 2014;28(2):158-75. [DOI: 10.1177/0269216313491619]">Antunes 2014</a>). If this is not feasible, for example for ethical reasons, the perspectives of family members, carers, or clinicians can be assessed. The average age of participants receiving the interventions was rather high, reflecting that COVID‐19‐related mortality increases with age (<a href="./references#CD015061-bbs2-0105" title="WilliamsonE , WalkerAJ , BhaskaranKJ , BaconS , BatesC , MortonCE , et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature2020;584:430-6. [DOI: 10.1038/s41586-020-2521-4]">Williamson 2020</a>). The pharmacological interventions used in the studies are commonly used in palliative care: opioids for relief of pain and dyspnea, neuroleptics for relief or prophylaxis of nausea and vomiting and relief of agitation/delirium, anticholinergics for relief of cough and death rattle, and benzodiazepines for relief of dyspnea, agitation, delirium, and for palliative sedation when necessary (<a href="./references#CD015061-bbs2-0038" title="BauseweinC , VoltzR , SteffenS , RadbruchL . Evidence-based guideline: Palliative care for patients with incurable cancer. www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Palliativmedizin/Version_2/LL_Palliativmedizin_Langversion_2.2.pdf (accessed 26 July 2021). [AWMF-REGISTRATION NUMBER: 128/001OL]">Bausewein 2020</a>). The included studies were not designed to provide detailed information on the effectiveness and safety of every used medication. We did not identify any study exploring non‐pharmacological interventions for palliative symptom control in people with COVID‐19. The review question could therefore not be properly answered by the available evidence. </p> <p>We identified one controlled study investigating the effectiveness of morphine for dyspnea in individuals with COVID‐19 in a controlled setting that is still ongoing (<a href="./references#CD015061-bbs2-0032" title="NCT04522037. Measurement of the efficacy of morphine in the early management of dyspnea in COVID-19 positive patients (CODYS). clinicaltrials.gov/ct2/show/NCT04522037 (first received 21 August 2020). ">NCT04522037</a>), and one RCT investigating the effects of acupressure therapy and Liu Zi Jue Qigong exercises on dyspnea and quality of life in individuals with COVID‐19 that has not yet published results (<a href="./references#CD015061-bbs2-0028" title="ChiCTR2000029994. Liu-Zi-Jue qigong and acupressure therapy for pulmonary function and quality of life in patient with severe novel coronavirus pneumonia (COVID-19): A randomized controlled trial. Chinese Clinical Trial Registry2020. [CHICTR: 2000029994] [URL: https://www.chictr.org.cn/showprojen.aspx?proj=49309]ZhangS , ZhuQ , ZhanC , ChengW , MingfangX , FangM ,  et al. Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial. Trials2020;21(1):751. [DOI: 10.1186/s13063-020-04693-5]">ChiCTR2000029994</a>). We further identified abstracts to three studies that might have relevant information on palliative symptom control once full texts are published (<a href="./references#CD015061-bbs2-0029" title="GroningerH , McPhersonA , VaughanE , KangIG , KelemenA . Hospital-based palliative care experiences of patients with COVID-19. Journal of Pain and Symptom Management2021;61(3):695. [ABSTRACT NUMBER: SCI947] [DOI: 10.1016/j.jpainsymman.2021.01.108]">Groninger 2021</a>; <a href="./references#CD015061-bbs2-0030" title="KellyL , O’SheaN , AzharM , BeattyS , BrennockJ , MannionE , et al. Symptomatology at the end of life with COVID-19. Abstracts of the 16th International E-Congress of the European Geriatric Medicine Society; 2020 Oct 7-9 2020 Apr 28 [Epub ahead of print]. [ABSTRACT NUMBER: 23] [DOI: 10.1007/s41999-020-00428-6]">Kelly 2020</a>; <a href="./references#CD015061-bbs2-0031" title="OkuwogaO , PictonS , SaberS ,  O’SullivanC . Managing delirium in patients with COVID-19—lessons to learn. Abstracts of the 16th International E-Congress of the European Geriatric Medicine Society; 2020 Oct 7-9 2020 Apr 28 [Epub ahead of print]. [ABSTRACT NUMBER: 281] [DOI: 10.1007/s41999-020-00428-6]">Okuwoga 2020</a>). Results from these studies might add relevant information to this review and possibly necessitate an update. </p> </section> <section id="CD015061-sec-0085"> <h3 class="title" id="CD015061-sec-0085">Quality of the evidence</h3> <section id="CD015061-sec-0086"> <h4 class="title">Certainty of the evidence</h4> <section id="CD015061-sec-0087"> <h5 class="title">Pharmacological interventions for palliative symptom control</h5> <p>We assessed the certainty of evidence for the outcome symptom relief. None of the other prioritized outcomes of this review were reported in the included studies. </p> <p>We have very low confidence in the identified evidence on symptom relief. All identified studies had a retrospective and uncontrolled design, thus the initial level of certainty was rated as low. Furthermore, we downgraded the level of certainty once because of study limitations due to risk of bias and confounding, reaching a very low level of certainty. Serious study limitations led to a judgement of high risk of detection and selection bias. Studies were not adjusted for potential confounders (e.g. age or gender of participants). It was difficult to assess imprecision and publication bias for the available studies, as results were not quantifiable. </p> <p>We did not identify any studies reporting on the effects of pharmacological interventions on quality of life; satisfaction of patients, caregivers, or relatives; and symptom burden in people dying of COVID‐19, thus we cannot make a judgement on how to best address these outcomes. We also did not identify any studies reporting on adverse events or serious adverse events, and therefore do not know which adverse events, if any, are associated with pharmacological interventions.  </p> </section> <section id="CD015061-sec-0088"> <h5 class="title">Non‐pharmacological interventions for palliative symptom control</h5> <p>We do not know whether non‐pharmacological interventions are effective and safe for palliative symptom control in people with endstage COVID‐19, because we did not identify any studies investigating non‐pharmacological interventions. </p> </section> </section> </section> <section id="CD015061-sec-0089"> <h3 class="title" id="CD015061-sec-0089">Potential biases in the review process</h3> <p>To avoid potential bias in the review process, we were committed at all times to conduct a systematic review that followed published guidance in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD015061-bbs2-0052" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>).  </p> <p>While we published a protocol for this review beforehand (<a href="./references#CD015061-bbs2-0108" title="AndreasM , PiechottaV , BeckerG , Metzendorf M-I, SkoetzN , MeissnerW , et al. Palliative symptom management in Covid-19 patients: a systematic review. PROSPERO. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021233630. 2021.">Andreas 2021</a>), we did not publish a peer‐reviewed Cochrane Review protocol due to time constraints for this high‐priority review in this very critical area of research during the COVID‐19 pandemic. This review was based on a peer‐reviewed protocol of a series on interventions for COVID‐19 (<a href="./references#CD015061-bbs2-0093" title="ValkSJ , PiechottaV , KimberC , ChaiKL , MonsefI , DoreeC , et al. Convalescent plasma and hyperimmune immunoglobulin to prevent infection with SARS-CoV-2. Cochrane Database of Systematic Reviews2021, Issue 1. Art. No: CD013802. [DOI: 10.1002/14651858.CD013802]">Valk 2020b</a>). However, since PICOs between the reviews differ, this could potentially lead to bias. </p> <p>As COVID‐19 is a novel disease, results from RCTs are not yet available for palliative symptom control. Consequently, we included only data from retrospective cohort studies. As little guidance exists on how to synthesize studies where meta‐analysis is not possible, we had to develop an appropriate synthesis method. Our approach was informed by the SWiM (Synthesis Without Meta‐analysis) guideline, <a href="./references#CD015061-bbs2-0041" title="CampbellM , McKenzieJE , SowdenA , KatikireddiSV , BrennanSE , EllisS , et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ2020;368(l6890):1-6. [DOI: 10.1136/bmj.l6890]">Campbell 2020</a>, and Chapter 24 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD015061-bbs2-0078" title="ReevesBC , DeeksJJ , HigginsJPT , SheaB , TugwellP , WellsGA . Chapter 24: Including non‐randomized studies on intervention effects. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Reeves 2021</a>). We used a mixed approach of visual and written presentation to provide the reader support in the interpretation of results; however, results without robust data might be misleading or overstated. </p> <p>An experienced Information Specialist developed a sensitive search strategy to identify all ongoing and completed studies. The search strategy was peer‐reviewed by another experienced Information Specialist. We searched all relevant databases and trial registries, and two review authors conducted all review steps independently and in duplicate. In the case of missing data, we contacted study authors for additional data or relevant details as needed. We are confident that we identified all relevant studies, and will monitor ongoing studies as well as studies that have been completed but that are not yet published closely after the publication of this review.   </p> <p>We identified no other potential sources of bias in our review process. </p> </section> <section id="CD015061-sec-0090"> <h3 class="title" id="CD015061-sec-0090">Agreements and disagreements with other studies or reviews</h3> <p>We have identified no other systematic review assessing palliative symptom control in COVID‐19 patients. However, we did identify non‐systematic reviews addressing palliative symptom control in COVID‐19 patients. We agree with the review by <a href="./references#CD015061-bbs2-0057" title="KeeleyP , BuchananD , CarolanC , PivodicL , TavabieS , NobleS . Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary. BMJ Supportive &amp; Palliative Care2020;10(4):381-4. [DOI: 10.1136/bmjspcare-2020-002368]">Keeley 2020</a> that more information on palliative care for COVID‐19 patients is urgently needed. Symptoms addressed in other reviews and this review seem to be similar: cough, anxiety, pain, and dyspnea are reported to be prevalent among COVID‐19 patients (<a href="./references#CD015061-bbs2-0070" title="Mottiar M, Hendin A, FischerL , des Ordons AR,  Hartwick M. End-of-life care in patients with a highly transmissible respiratory virus: implications for COVID-19. Canadian Journal of Anaesthesia2020;67:1-7. [DOI: 10.1007/s12630-020-01699-0]">Mottiar 2020</a>; <a href="./references#CD015061-bbs2-0091" title="Ting R,  Edmonds P,  Higginson IJ,  Sleeman KE. Palliative care for patients with severe covid-19. BMJ2020;370:m2710. [DOI: 10.1136/bmj.m2710]">Ting 2020</a>). </p> <p>Pharmacological interventions found in this review are similar to those that are recommended for the palliative care of cancer patients (<a href="./references#CD015061-bbs2-0038" title="BauseweinC , VoltzR , SteffenS , RadbruchL . Evidence-based guideline: Palliative care for patients with incurable cancer. www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Palliativmedizin/Version_2/LL_Palliativmedizin_Langversion_2.2.pdf (accessed 26 July 2021). [AWMF-REGISTRATION NUMBER: 128/001OL]">Bausewein 2020</a>). Furthermore, the pharmacological interventions used for symptom control found in this review are also recommended by the German Society for Palliative Medicine (<a href="./references#CD015061-bbs2-0072" title="NehlsW , DelisS , HaberlandB , MaierBO , SängerK , TessmerG , et al. Management of patients with COVID-19—recommendations from a palliative care perspective. Pneumologie2020;774(10):652-9. [DOI: 10.1055/a-1156-2759]">Nehls 2020</a>). We did not find any evidence on recommended non‐pharmacological interventions, as have been put forward by the National Institute for Health and Care Excellence (NICE) (<a href="./references#CD015061-bbs2-0073" title="National Institute for Health and Care Excellence (NICE). Managing COVID-19 symptoms (including at the end of life) in the community: summary of NICE guidelines. BMJ2020;369:m1461. [DOI: 10.1136/bmj.m1461]">NICE 2020</a>).  </p> <p>More information is needed to investigate specific challenges for palliative care in the COVID‐19 pandemic. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD015061-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/urn:x-wiley:14651858:media:CD015061:CD015061-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD015061-fig-0001" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_t/tCD015061-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015061-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/urn:x-wiley:14651858:media:CD015061:CD015061-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Summary of risk of bias. " data-id="CD015061-fig-0002" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_t/tCD015061-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Summary of risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015061-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/urn:x-wiley:14651858:media:CD015061:CD015061-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Visual synthesis of Alderman 2020" data-id="CD015061-fig-0003" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-03.jpg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_t/tCD015061-FIG-03.jpg" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Visual synthesis of Alderman 2020</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-03.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015061-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/urn:x-wiley:14651858:media:CD015061:CD015061-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Visual synthesis for Alderman 2020" data-id="CD015061-fig-0004" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-04.jpg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_t/tCD015061-FIG-04.jpg" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Visual synthesis for Alderman 2020</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-04.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015061-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/urn:x-wiley:14651858:media:CD015061:CD015061-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Visual synthesis for Hetherington 2020" data-id="CD015061-fig-0005" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-05.jpg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_t/tCD015061-FIG-05.jpg" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Visual synthesis for Hetherington 2020</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-05.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015061-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/urn:x-wiley:14651858:media:CD015061:CD015061-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Visual synthesis for Lovell 2020" data-id="CD015061-fig-0006" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-06.jpg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_t/tCD015061-FIG-06.jpg" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Visual synthesis for Lovell 2020</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-06.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015061-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/urn:x-wiley:14651858:media:CD015061:CD015061-FIG-07" target="_blank"><b></b></a></p> </div><img alt="Visual synthesis for Strang 2021a" data-id="CD015061-fig-0007" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-07.jpg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_t/tCD015061-FIG-07.jpg" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Visual synthesis for Strang 2021a</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-07.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015061-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/urn:x-wiley:14651858:media:CD015061:CD015061-FIG-08" target="_blank"><b></b></a></p> </div><img alt="Visual synthesis for Strang 2021a" data-id="CD015061-fig-0008" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-08.jpg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_t/tCD015061-FIG-08.jpg" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Visual synthesis for Strang 2021a</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-08.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015061-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/urn:x-wiley:14651858:media:CD015061:CD015061-FIG-09" target="_blank"><b></b></a></p> </div><img alt="Visual synthesis for Strang 2021a" data-id="CD015061-fig-0009" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-09.jpg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_t/tCD015061-FIG-09.jpg" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Visual synthesis for Strang 2021a</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-09.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015061-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/urn:x-wiley:14651858:media:CD015061:CD015061-FIG-10" target="_blank"><b></b></a></p> </div><img alt="Visual synthesis for Strang 2021b" data-id="CD015061-fig-0010" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-10.jpg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_t/tCD015061-FIG-10.jpg" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p>Visual synthesis for Strang 2021b</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-10.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015061-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/urn:x-wiley:14651858:media:CD015061:CD015061-FIG-11" target="_blank"><b></b></a></p> </div><img alt="Visual synthesis for Strang 2021b" data-id="CD015061-fig-0011" src="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-11.jpg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_t/tCD015061-FIG-11.jpg" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 11</div> <div class="figure-caption"> <p>Visual synthesis for Strang 2021b</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015061/media/CDSR/CD015061/image_n/nCD015061-FIG-11.jpg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD015061-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Pharmacological interventions for palliative symptom control</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Pharmacological interventions for palliative symptom control for patients with COVID‐19</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients with COVID‐19 </p> <p><b>Intervention:</b> Pharmacological interventions </p> <p><b>Comparison:</b> None </p> <p><b>Outcome:</b> Palliative symptom control </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcome</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number of participants</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Certainty of the evidence</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Plain text summary</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptom relief</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 studies (5 references) with 61 to 2105 participants in individual studies<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>All studies rated a majority of interventions as effective in relieving symptoms of breathlessness, agitation, dyspnea, delirium, pain, and others. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Very low</b> </p> <p>Due to study design<sup>2</sup> and high risk of bias<sup>3</sup> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are very uncertain about the effect of palliative care interventions including opioids, neuroleptics, anticholinergics, and benzodiazepines on symptom relief. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Based on data from 0 participants in 0 studies</p> <p>Follow‐up: none</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported in any study.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptom burden</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Based on data from 0 participants in 0 studies</p> <p>Follow‐up: none</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported in any study.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction of patients</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Based on data from 0 participants in 0 studies</p> <p>Follow‐up: none</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported in any study.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction of caregivers </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Based on data from 0 participants in 0 studies</p> <p>Follow‐up: none</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported.<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported in any study.<br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction of relatives</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Based on data from 0 participants in 0 studies</p> <p>Follow‐up: none</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported in any study.<br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Based on data from 0 participants in 0 studies</p> <p>Follow‐up: none</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported.<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported in any study.<br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grade 3 to 4 adverse events<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Based on data from 0 participants in 0 studies</p> <p>Follow‐up: none</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported.<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported in any study.<br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>N/A: Not applicable </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>1</sup>Participants of the two cohorts reported on in <a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]">Strang 2021</a> partially overlap, therefore we do not know the exact number of participants. </p> <p><sup>2</sup> Initial rating of certainty of the evidence: Rated low because all identified studies had a retrospective and uncontrolled design. <br/><sup>3</sup>Risk of bias: high. Lack of blinding of participants and personnel, resulting in the potential for detection bias in all studies. Lack of blinding of outcome assessors, resulting in the potential for detection bias in all studies. Selective outcome reporting, follow‐up not reported, missing intention‐to‐treat analysis, use of unvalidated outcome measures in <a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]">Alderman 2020</a>, <a href="./references#CD015061-bbs2-0003" title="LovellN , MaddocksM , EtkindSN , TaylorK , CareyI , VoraV , et al. Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care. Journal of Pain and Symptom Management2020;60(1):e77-81. [DOI: 10.1016/j.jpainsymman.2020.04.015]">Lovell 2020</a>, and <a href="./references#CD015061-bbs2-0002" title="HetheringtonL , JohnstonB , KotronoulasG , FinlayF , KeeleyP , McKeownA . COVID-19 and hospital palliative care—a service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist hospital palliative care. Palliative Medicine2020;34(9):1256-62. [DOI: 10.1177/0269216320949786]">Hetherington 2020</a>, and use of subjective outcome measures in all studies. Imprecision: none. Publication bias: none. Inconsistency: difficult to assess. Indirectness of evidence: difficult to assess.  </p> <p> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Pharmacological interventions for palliative symptom control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD015061-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Risk of bias assessment criteria for observational studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Internal validity</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>External validity</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study group</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Selection bias</b> (unrepresentative study group)<br/>  </p> <p>The study group was considered representative,</p> <p> <ul id="CD015061-list-0010"> <li> <p>if the described study group consisted of &gt; 80% of individuals with COVID‐19 treated with palliative symptom control </p> </li> </ul> </p> <p><b>or</b> </p> <p> <ul id="CD015061-list-0011"> <li> <p>if it was a random sample with respect to the treatment and important prognostic factors.</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reporting bias</b> (poorly defined study group)<br/>  </p> <p>The study group was considered as well defined,</p> <p> <ul id="CD015061-list-0012"> <li> <p>if the study population is well described (e.g. severity of disease, age, risk factors)</p> </li> </ul> </p> <p><b>and</b> </p> <p> <ul id="CD015061-list-0013"> <li> <p>the intervention is well described (e.g. number of doses, volume).</p> </li> </ul> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Follow‐up</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Attrition bias</b> (incomplete outcome assessment/follow‐up ) </p> <p>The outcome assessment and follow‐up was considered as complete,</p> <p> <ul id="CD015061-list-0014"> <li> <p>if the outcome was assessed for &gt; 90% of the study group of interest (++)</p> </li> </ul> </p> <p><b>or</b> </p> <p> <ul id="CD015061-list-0015"> <li> <p>if the outcome was assessed for 60% to 90% of the study group of interest (+).</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reporting bias</b> (poorly defined follow‐up) </p> <p>The follow‐up was considered as well defined,</p> <p> <ul id="CD015061-list-0016"> <li> <p>if the length of follow‐up was mentioned.</p> </li> </ul> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Detection bias</b> (outcome assessors unblinded to investigated determinant) </p> <p>The detection bias was considered as low,</p> <p> <ul id="CD015061-list-0017"> <li> <p>if the outcome assessors were blinded to the investigated determinant.</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reporting bias</b> (poorly defined outcome) </p> <p>The outcome definition was considered as well defined,</p> <p> <ul id="CD015061-list-0018"> <li> <p>if the outcome definition was objective and precise, and the method of detection was provided. </p> </li> </ul> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Risk estimation</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Confounding</b> (important prognostic factors or follow‐up not adequately taken into account) </p> <p>Risk of confounding was considered as low,</p> <p> <ul id="CD015061-list-0019"> <li> <p>if important prognostic factors (i.e. age, co‐treatment, comorbidities) or follow‐up were adequately taken into account. </p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Analyses</b> (poorly defined risk estimates) </p> <p>The risk estimates were considered as well defined,</p> <p> <ul id="CD015061-list-0020"> <li> <p>if a risk ratio, odds ratio, attributable risk, linear or logistic regression model, mean difference, or Chi<sup>2</sup> was calculated. </p> </li> </ul> </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Risk of bias assessment criteria for observational studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD015061-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overview of included studies </span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b> </b> </p> <p><b> </b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD015061-bbs2-0001" title="AldermanB , WebberK , DaviesA . An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom. Palliative Medicine2020;34(9):1249-55. [DOI: 10.1177/0269216320947312]"><b>Alderman 2020</b> </a> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD015061-bbs2-0002" title="HetheringtonL , JohnstonB , KotronoulasG , FinlayF , KeeleyP , McKeownA . COVID-19 and hospital palliative care—a service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist hospital palliative care. Palliative Medicine2020;34(9):1256-62. [DOI: 10.1177/0269216320949786]"><b>Hetherington 2020</b> </a> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD015061-bbs2-0003" title="LovellN , MaddocksM , EtkindSN , TaylorK , CareyI , VoraV , et al. Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care. Journal of Pain and Symptom Management2020;60(1):e77-81. [DOI: 10.1016/j.jpainsymman.2020.04.015]"><b>Lovell 2020</b> </a> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><a href="./references#CD015061-bbs2-0004" title="StrangP , BergströmJ ,  LundströmS . Symptom relief is possible in elderly dying COVID-19 patients: a national register study. Journal of Palliative Medicine2020;24(4):514-9. [DOI: 10.1089/jpm.2020.0249]StrangP , MartinssonL , BergströmJ , LundströmS . COVID-19: symptoms in dying residents of nursing homes and in those admitted to hospitals. Journal of Palliative Medicine 2021 Mar 5 [Epub ahead of print]. [DOI: 10.1089/jpm.2020.0688]"><b>Strang 2021</b> </a> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>Study characteristics</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Setting</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015061-list-0028"> <li> <p>Hospital</p> </li> <li> <p>United Kingdom</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015061-list-0029"> <li> <p>Hospital</p> </li> <li> <p>United Kingdom</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015061-list-0030"> <li> <p>Hospital</p> </li> <li> <p>United Kingdom</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015061-list-0031"> <li> <p>Hospitals and nursing homes</p> </li> <li> <p>Sweden</p> </li> </ul> </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Design</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective cohort study</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Protocol</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None published.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None published.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None published.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None published.</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Number of participants</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>186</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unknown*</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Symptoms treated</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Shortness of breath, delirium, audible upper airway secretions, cough, pain, nausea</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort 1: breathlessness,     anxiety, delirium, audible upper airway secretions, pain  </p> <p>Cohort 2: breathlessness, anxiety, delirium, respiratory secretions</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcome assessed </b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptom relief (assessed by clinicians)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cinical impression of efficacy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical impression of effectiveness </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptom relief (assessed by clinicians)</p> </td> </tr> <tr> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b> </b> </p> </th> <th align="" class="headercell" colspan="4" rowspan="1" scope="col" valign=""> <p><b>Participant characteristics</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Age of participants </b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median age 82 (IQR 53 to 98) years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median age 76 (IQR 71 to 84) years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median age 82 (IQR 72 to 89) years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>First cohort: mean age 84.7 (range 47 to 104)</p> <p>Second cohort: </p> <p> <ul id="CD015061-list-0032"> <li> <p>Nursing homes: 86.7 (range 57 to 107)</p> </li> <li> <p>Hospitals: 83.3 (range 30 to 107)</p> </li> </ul> </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gender (male (n (%)))</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34 (55.5%)    </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98 (52.6%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64 (45.5%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cohort 1: 201 (52%) </p> <p>Cohort 2: </p> <p> <ul id="CD015061-list-0033"> <li> <p>Nursing homes: 1084 (57%)</p> </li> <li> <p>Hospitals: 74 (42%)</p> </li> </ul> </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comorbidities (%)</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dementia (13%), neurological disease (8%), cardiovascular disease (42.5%), hypertension (36%), respiratory disease (23%), renal disease (18%), diabetes mellitus (19.5%), cancer (24.5%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertension (31.2%), diabetes mellitus (28%), chronic obstructive pulmonary disease (26.9%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertension (53%), diabetes (35.6%), dementia (30.6%), <br/>advanced/metastatic cancer (24.7%), chronic pulmonary disease (21.7%), renal failure (20.7%), congestive heart failure (17.8%), stroke/neurological disorder (11.8%), peripheral vascular disorder (0.04%), liver disease (0.02%)<br/>  </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None reported. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>Abbreviations: IQR: interquartile range</p> <p>*We do not know the exact number of participants since the cohorts reported on partially overlap. The first cohort included 390 participants, and the second cohort 2105 participants. It is unclear how big the overlap is between patients who died in hospitals in the first cohort (137) and nursing home residents who died in hospitals in the second cohort.  </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Overview of included studies </span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD015061/full#CD015061-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD015061&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD015061-note-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD015061-note-0011">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD015061-note-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD015061-note-0010">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD015061-note-0009">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD015061-note-0015">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD015061-note-0007">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD015061-note-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD015061-note-0017">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD015061-note-0006">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD015061-note-0014">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD015061-note-0012">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD015061-note-0013">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015061\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015061\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015061\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD015061"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015061\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015061\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015061\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015061\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015061\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD015061"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015061\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015061\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015061\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD015061"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015061\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015061\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015061\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD015061"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=wbKFI7vu&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD015061&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD015061';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD015061/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD015061/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD015061%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719436511"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD015061/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719436515"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD015061/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918de8b7985af55b',t:'MTc0MDcxOTQzNi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 